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CHAPTER I. 
INTRODUCTION 
Acute hepatic failure (AHF) is one of the most dramatic situations that a 
clinical physician can encounter. It is also one of the most frustating since 
death is the result in a large majority of the cases, despite all efforts of 
the medical and nursing staffs. Although a wide variety of experimental 
modalities has been devised to treat the syndrome, none has proven to be 
effective (1,2) and 80 to 90% of those with stage IV disease die (3,4). This 
prognosis is in marked contrast to that for renal failure, that has undergone 
a steady improvement in survival statistics in the past decades - largely as 
a result of rapidly improving artificial kidney devices (5,6). The continuing 
bleak prognosis for the patient with fulminant hepatic failure has stimulated 
investigation into the feasibility of developing some sort of artificial 
device which would take over the essential life-preserving functions of the 
liver. The basic therapeutic approach to AHF must be intensive care 
monitoring, treatment of complications, synthetic replacement of certain 
functions of the liver and detoxification, i.e. the removal of toxic 
substances which accumulate in fulminant hepatic failure (7). The rationale 
for detoxification is based on the observation that the accumulation of 
'toxins' is related to the development of hepatic encephalopathy and cerebral 
edema (8), which influence survival (9). 
Synthetic support of various functions of the liver includes: 
l. Regulation of the glucose homeostasis; hypoglycaemia develops in 40-50% 
of the patients with severe liver damage (10,11,12). Inefficient degradation 
of insulin as well as deficiencies in gluconeogenesis has been suggested as 
the possible cause (13). Continuous administration 
prevents hypoglycaernia; however, 
continues to be necessary. 
frequent monitoring 
of glucose 
of blood 
usually 
glucose 
2. Correction of clotting deficiencies; more than 50% of patients with 
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fulminant hepatic failure develop severe haemorrhage, usually in the upper 
gastro-intestinal tract but also in the nose, lungs or the retroperitoneal 
space. Fresh frozen plasma and blood are give to replace the missing clotting 
factors (9). Concentrated clotting factors should not be given because they 
enhance the process of disseminated intravascular coagulation. Vitamin K may 
be given but the effect on prothrombin time is usually insignificant. In 
addition to supplementing clotting factors, fresh frozen plasma may also help 
to restore the oncotic pressure and correct deficiencies of opsonins and 
complement factors (14). 
Support of the detoxifying function of the liver 
In acute hepatic failure many substances accumulate. Restoration of the 
'internal milieu 1 is the main goal of therapy, resulting in reduction of 
hepatic encephalopathy, prevention of cerebral edema and enhancement of liver 
regeneration. The development of artificial hepatic support systems has 
proceeded empirically due to our ignorance of the toxins to be removed and 
the metabolic abnormalities to be corrected. A number of different approaches 
to the development of such systems has been proposed (7) and several have 
been brought into clinical use after only a minimum of 'in vitro' and animal 
testing. 
What should a support system be able to do? 
The substances that probably 
encephalopathy can be divided 
molecular size. 
are involved in the pathogenesis of hepatic 
into three groups on the basis of their 
Firstly, three groups of small molecular water-soluble substances have 
been implicated in the pathogenesis of hepatic encephalopathy (8) , 
a. Ammonia, short-chain fatty acids and mercaptanes, acting either alone or 
synergistically (15,16). 
b. Plasma amino acids. An imbalance of these substances will result in an 
increased brain uptake of free tryptophan, phenylalanine and tyrosine and 
interruption of the balance between inhibitory and excitatory 
neurotransmitters (17). 
c. GABA. Increased brain GABA bound to an increased number of GABA receptors 
results in neural inhibition with subsequent encephalopathy (18, 19, 20). 
The origin of GABA is not exactly understood; some authors believe that 
it is produced in the colon (19,21). 
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Secondly, middle molecular substances with a molecular weight between 1000 
and 5000 daltons, although as yet not identified, have been demonstrated in 
the serum (22,23,24) and brain (22) of comatose animals and men. 
The third category of substances that could be involved in the 
pathogenesis of hepatic encephalopathy is those bound to proteins. Although 
specific protein-bound toxins have as yet not been identified, bilirubin and 
bile acids may serve as markers for this category. 
An ideal hepatic support system should be capable of removing all three 
groups of molecular substances adequately. 
Because of the complexity of the abnormal metabolic state one simple 
artificial device is unlikely to be able to normalize all disturbances of the 
'internal milieu'. However the use of the available systems, for example 
haemodialytic procedures and haemoperfusion on charcoal or resins, may allow 
us to study the role of specific toxins in the pathogenesis of hepatic 
encephalopathy. 
Studies on the treatment of acute hepatic failure. 
Evaluation of the effect of hepatic support in animal experiments is only 
useful if the model can be compared with the human situations and if there is 
a reliable and objective method for measuring hepatic encephalopathy. A lack 
of both criteria has strongly hampered research in this field. 
The main purpose of this thesis is: 
l. To develop an animal model for acute hepatic failure by inducing 
transient ischaemia of the liver (Chapter II). 
2. To measure hepatic encephalopathy by objective methods, such as spectral 
analysis of the EEG and evoked potentials (Chapter III). 
3. To validate the cause of death by hepatic failure and to exclude the 
presence of endotoxaemia in pigs treated with oral lactulose and 
magnesiumsulfate (Chapter IV). 
4. To study the effect of large-pore membrane haemodialysis, cross dialysis 
and haemofiltration on survival and the neurologic state in pigs with 
ischaemic hepatic necrosis and also to determine the removal of freely 
diffusable and protein-bound substances by various haemodialytic 
procedures. (Chapter V and VI). 
5. To discuss the efficacy of the presently used artificial organs in acute 
hepatic failure with a view to the future (Chapter VII). 
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Abstract 
A model of transient acute hepatic failure has been developed in the pig. 
Three days after a functional end-to-side portocaval shunt was introduced, 15 
ambulant animals underwent total liver ischemia for 4 or 6 hours by the 
closure of a mechanical clamp surrounding the hepatic artery. Four of the 8 
animals subjected to 4 hours of ischemia survived. All but one of the animals 
undergoing 6 hours of hepatic ischemia developed grade 4 encephalopathy after 
24 to 30 hours and died within 50 hours. Quantitative estimation of liver 
cell necrosis revealed less than 40% necrosis in the survivors, and 
approximately 62% (range 49-75%) in animals who died of hepatic coma. As far 
as the putative toxins are concerned, significant differences were found 
between animals undergoing 4 and those undergoing 6 hours of ischemia, 
especially in the plasma ammonia levels and the plasma ratio's for tyrosine 
and phenylalanine. Plasma arginine levels had fallen to zero in both groups 
at 24 hours and only rose to pre-ischem'ic values in animals who survived. 
This large animal model fulfills the accepted criteria of potential 
reversibility, reproducibility and death due to hepatic failure. 
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Introduction 
To evaluate new therapies for human fulminant hepatic failure a suitable 
animal model is urgently needed. Surgical models such as hepatectomy (1) or 
a portocaval shunt with permanent ligation of the hepatic artery in one or 
two stages (2,3) are not ideal because they lack both potential reversibility 
(4) and the release of products from damaged liver cells into the 
circulation. To overcome these problems Misra (5) and Fisher (6) created a 
model of reversible hepatic ischemia in ambulant conscious dogs and pigs, 
respectively. Sixty minutes of hepatic ischemia were always fatal to dogs. 
For pigs, the minimum period of hepatic ischemia required to produce death 
due to hepatic coma could not be estimated; according to other investigators 
the period of hepatic ischemia tolerated by pigs varied between 35 and 180 
minutes (7-10). Hepatic encephalopathy however could not be induced in these 
studies, since the animals either survived or died without a definite period 
of clinically manifest neurological abnormalities. 
The aim of our investigation was to develop a model of acute hepatic 
failure by inducing temporary hepatic ischemia in fully ambulant pigs, and to 
describe the clinical, biochemical, hemodynamic, histological and 
electrophysiological features of this model. 
Material and Methods 
Preparatory surgery. 
Fifteen healthy White pigs, weighing 28-33 kg, were used. One and two days 
before surgery, the bowel was cleansed by the oral administration of 25 g of 
magnesium sulfate and 150 ml of lactulose. Anesthesia was induced with an 
intramuscular injection of ketamine chloride (35 mg/kg) The animal was 
intubated and connected to a BA-4 
maintained with a mixture of N0 2-o2 
Anesthesia Ventilator; anesthesia 
and EthraneR. The anesthetized pig 
was 
was 
placed on the operating table in a supine position. A Scribner shunt was 
inserted between the carotid artery and external jugular vein for pressure 
monitoring and blood sampling. The internal jugular vein was cannulated with 
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-Fig 1. View of the mechanical clamp used to occlude the hepatic artery of 
fully alert pigs. 
Arterial hepatic 
blood flow 
BP 
140 
1 00 
60 
20 
clamped un-clamped 
• ~ 
Fig 2. Blood flow curve of the hepatic artery and systemic blood pressure 
before, during and after clamping of the hepatic artery. 
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a polyethylene cannula for infusion of intravenous fluids. After opening the 
abdomen with a long midline incision the liver was freed by dissecting the 
triangular ligaments, the falciform ligament and all peritoneal attachments 
of the liver. All structures in the hepatoduodenal ligament except the portal 
vein, the hepatic artery and the common duct were divided. Blood vessels 
running along the vena cava into the liver at the level of the diafragm were 
interrupted by diathermia. 
A side-to-side portocaval shunt was made, followed by ligation and 
transection of the portal vein close to the hilum to create a functional 
end-to-side shunt. A specially constructed vessel occluder (fig.l) and a 
perivascular electromagnetic blood flow sensor (Skalar, Delft, the 
Netherlands) were positioned around the isolated hepatic artery; they were 
anchored to the abdominal wall and the leads were guided through the skin via 
separate incisions. The occluder and flow probe were tested during surgery by 
tightening the occluder, which resulted in a total flattening of the blood 
flmv curve on the oscilloscope (fig. 2). 
The common bile duct was opened and a silicon tubing was inserted. This 
drain was firmly attached by two 2-0 silk ligatures around the proximal and 
distal ends of the drain, thus preventing blood flow through the wall of the 
common bile duct to the liver. Abdominal closure was performed in two layers. 
Subsequently five silver electrodes (diameter:;l mm) were positioned upon 
the dura, anchored in the skull with acrylic bone cement and channeled 
percutaneously; two electrodes were placed above the frontal cortex, one in 
the vertex and two above the occipital cortex. With this technique 
artefact-free registration of the electroencephalograms was possible. After 
discontinuation of anesthesia the animals were kept on the operating table 
until they were awake, breathing adequately and restoring their body 
temperature. 
Throughout the surgical procedure 0.9% NaCl was administered; just before 
construction of the portocaval anastomosis an additional dose of 400 ml of 
Haemacel was given intravenously. At the beginning of surgery and immediately 
afterwards ampicilline (0.5 gr) and kanamycin (0.5 gr) were injected 
intravenously. 
Induction of ischemic necrosis. 
Three days after construction of the portocaval shunt the normothermic 
animals, fully awake, were fixed on a table with two cotton sheets. The 
animals accepted this procedure. Ischemic hepatic necrosis was induced by 
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tightening the clamp around the hepatic artery; arrest of hepatic blood flow 
was confirmed by total flattening of the flow curve on the oscilloscope 
(fig.2). Arterial occlusion was maintained for 4 and 6 hours, respectively. 
To validate the total devascularization of the liver, two animals underwent 
aortography and selective angiography of the hepatic artery, After unloc~ing 
the clamp, restoration of blood flow through the hepatic artery was confirmed 
by continuous registration of the electromagnetic flow measurements. 
All animals received 35 ml of 8.4% sodium bicarbonate within 15 minutes of 
declamping, followed by a continuous infusion of glucose (12 g/kg/24 hrs). 
Penicillin G (9 mega u/ 24 hrs), kanamycin (3g/24 hrs), potassium and 
phosphate (37 rnmol/ 24 hrs and 45 mmol/24 hrs, respectively) were added to 
the glucose. After the ischemic period, the animals were placed in special 
cages in which they could move around without disturbing their continuous 
infusion. Heart rate and mean arterial blood pressure, recorded with an 
electromanometric transducer, were registered continuously. Temperature was 
measured with a tele-thermometer. 
Neurologic assessment. 
The behavior of the animals after temporary ischemia of the liver was 
checked frequently. Standard auditory and pain stimuli were administered 
regularly and the responses were graded as follows: 0= absent; 1~ dubious; 2= 
present. Spontaneous grunting and muscular rigidity were also noted. The 
duration of survival was defined as the period between the induction of 
hepatic ischaemia and the time of death. 
Electroencephalograms were made before induction of hepatic necrosis and 
repeated at 24,30,48,54 and 72 hrs. Four bipolar tracings (left and right 
fronto-occipital, fronto-frontal and occipita-occipital leads) were recorded 
on a Gogh apparatus (Ahrend van Gogh, Amsterdam, the Netherlands). The EEG 
recordings were analyzed independently by an electroneurologist; the 5-grade 
classification described by Opolon (11) was used. 
Biochemical measurements. 
Blood samples were taken before and 24,30,48,54 and 72 hrs after induction 
of ischemic hepatic necrosis. In addition blood for acid-base status and 
coagulation studies was also drawn 0.5 hr and 1-3 hrs after release of the 
occlusive clamp. Blood glucose, sodium, 
SGOT, bilirubin, bile acids, platelets 
potassium, urea, pH, p02 and pC02, 
and clotting factors (fibrinogen, 
prothrombin time, activated partial thromboplastin time) were measured by 
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standard laboratory techniques. Blood samples were cultured in 60 ml of 
trypticase soy broth at 37° and observed for 2-3 days. 
Ammonia was measured by an enzymatic method (12). Plasma amino acid 
profiles were determined with a LKB-4400 amino acid analyzer (LKB Biochrom. 
Ltd, Cambridge, England) in plasma supernatant which had been rendered 
protein free by treatment with sulfosalicylic acid 75% w/v. The results for 
the neutral amino acids threonine, valine, leucine, isoleucine, tyrosine, 
phenylalanine, tryptophan, methionine and histidine are not expressed as 
simple concentrations but as plasma ratio's. The individual amino-acid ratio 
(for instance threonine) can be calculated as follows: THR/VAL + LEU + ILE + 
TYR + PRE + TRY + MET + HIS + THR. These neutral amino acids are transported 
by the same transport system in the blood-brain barrier (13). The ratio of 
the individual amino acids will reflect the influx of amino-acids into the 
brain. 
Morphology. 
Postmortem examinations were performed in all cases as soon as the animal 
died. After macroscopic inspection of the heart, lungs, kidney, stomach and 
portocaval anastomosis, the liver was removed. Two one em thick transverse 
slices from the upper and lower part of the liver were fixed in 10% 
formaldehyde. After fixation, 7-u sections of each complete transversal liver 
slide were stained with hematoxylin-eosin, PAS or gallocyanine. The degree of 
hepatic necrosis in each slide was estimated by point analysis (fig.3a,b); 
for this purpose 625 areas chosen at random were assessed for liver cell 
necrosis (defined as apparent disappearance of hepatocytes or eosinophilic 
condensation in the cytoplasm with nuclear pyknosis). 
Statistical analysis. 
Data are expressed as mean values ± SD. For unpaired samples with a normal 
distribution of data points, the Student's t test was used, while the 
Wilcoxon rank sum test was used in the event of a skewed data profile. 
Differences were assumed to be statistically significant when the p values 
were less than 0.05. 
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Fig 3a.A transverse cut of the liver (real size) with 25 points 
chosen at random for analysis of hepatic necrosis. 
Fig.3b.A magnification (objective lOx) of one area-point which again is 
divided into 25 points for analysis. 
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Results 
Adequacy of the ischemic procedure. 
For all animals, there was a total flattening of the blood flow curve on 
the oscilloscope during the ischemic period. Aortography and selective 
angiography of the liver of two animals showed complete devascularization of 
the liver. After release of the clamp, flow through the hepatic artery was 
restored in all animals as demonstrated by flow measurements (fig 2). 
Survival. 
After 4 hours of ischemia, four out of 8 pigs survived (fig. 4). Two 
animals died soon after hepatic ischemia due to technical complications 
(broken intravenous tubing and bile leakage from the tube); two other 
animals, that died 26 and 51 hours after ischemia, were found to have a 
positive blood culture with E.coli. After 6 hours of ischemia, 6 of the 7 
animals died within 50 hours; one animal survived for 72 hours with a grade 4 
encephalopathy. In four of the 6 animals death was due to hepatic coma; in 
the 2 remaining animals death was precipitated by a bleeding gastric ulcer. 
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Fig 4. Survival after induction of transient liver ischemia (4 hrs 
or 6 hrs of ischemia) in normothermic pigs. 
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Neurological assessment. 
The surviving animals undergoing four hours of ischaemia did not show 
marked abnormalities in behavior. Immediately after revascularization of the 
liver most pigs were ambulant and alert, although some appeared excited.The 
first abnormality observed in animals that ultimately died was usually an 
ataxic gait and impaired balance. The animals swayed from one side to the 
other; this was followed by drowsiness lasting several hours. Within 28 
hours, pain sensations and spontaneous grunting had decreased markedly. After 
loss of sensation coma developed between 24 and 30 hours after hepatic 
ischaemia and was accompanied by muscular twitching of the neck and limbs, 
and later rigidity. Some hours before death, tachycardia and 
hyperventilation were noted. Terminally, there was gasping with cyanosis, 
vomiting and hypotension. 
The courses of EEG grades for animals undergoing 4 and 6 hour periods of 
hepatic ischemia are shown in figure 5. The EEG grades became more abnormal 
in both groups after 24 hours. In general, the EEG changes deteriorated very 
slowly in '4-hour pigs'; only one animal had reached grade 4 encephalopathy 
at 48 hours. 'Six-hour pigs 1 showed a rapid deterioration of the EEG to 
grade 4 encephalopathy between 24 and 30 hours after the ischemic period. 
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Fig.S. The course of EEG grades in pigs after 4 and 6 hours of transient 
ischemia of the liver. The 6-hour animal, that survived for 
43 hours, has been included in the 48 hour group. 
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General and biochemical measurements. 
Heart rate and mean systemic blood pressure remained fairly constant, 
except during a short period immediately after revascularization of the liver 
(mean arterial blood pressure decreased by 20 mm Hg, and there was a mean 
increase in the heart rate of 18 beats per minute). Hypothermia did not 
develop during the experiments. Metabolic acidosis was observed after 
revascularization, but was easily corrected by administration of sodium 
bicarbonate (fig 6). The levels of plasma glucose, potassium and sodium 
remained within the normal range, also after release of the clamp. Plasma 
SGOT levels reached a maximum at 24 hours; 1 4-hour pigs' had lower levels 
(2073 ± 817 IU/l) at 24 hours than '6-hour animals 1 (3259 ± 1600 IU/1) (p.> 
0. 05) . 
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Coagulation factors (fig.7). 
A remarkable 
revascularization of 
decrease in platelets was observed 
9 the liver; the lowest value (66 x 10 /1) 
after the 
was recorded 
three hours after revascularization Platelet concentration increased 
gradually in 4-hour pigs but remained low in animals that underwent 6 hours 
of ischemia. The same course was observed for coagulation factors 
(prothrombin time, activated partial thromboplastin time and fibrinogen 
level). 
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of liver ischemia (o o). 
I: just before revascularization of the liver. 
II: 30 minutes after revascularization of the liver. 
III: 3 hours after revascularization of the liver. 
* p (0.05, comparison between '4 hour animals' and '6 hour animals'. 
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Fig 8. Plasma ammonia concentrations, and methionine, tyrosine, 
phenylalanine and tryptophane ratio's (mean± SD) in pigs subjected 
to 4 hours of liver ischemia (o---o) and with 6 hours of liver 
ischemia (.___.). 
* p < 0. 05, ** p { 0. 01, comparison between '4 hour animals' and 
'6 hour animals'. 
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Putative toxins (fig.8). 
Plasma ammonia was only moderately elevated at 24 hrs (162 ± 86 umol/1) in 
'4-hour pigs', in contrast to the levels found in animals undergoing 6 hours 
of ischemia: 283 ± 113 umol/1 at 24 hours. 
The plasma ratio's for leucine, isoleucine and valine decreased to a 
minimum level at 24 hrs after the ischemic period, without any difference 
between the 4 and 6-hour groups (Leucine from 20 to 12; Isoleucine from 15 to 
8 and valine from 32 to 20). The plasma ratio's for methionine, tyrosine and 
phenylalanine increased in both groups. In the 4-hour group, the plasma 
ratios for tyrosine and phenylalanine normalized to pre-ischemic values after 
48 hours, while the values for the 6-hour group remained significantly higher 
at 30 and 48 hours. Significant differences in the ratio for trypthophan 
were not found. With this relatively insensitive method, GABA levels could 
not be detected in plasma except in 2 animals (1.6-8.0 nmol/1). 
l4 JO 48 54 
hours after induction of ischemia 
Fig 9. Plasma arginine, ornithine and citrulline concentrations (mean± 
SD) in pigs after 4 hours of liver ischemia (o---o) and 6 hours 
of liver ischemia (----.). 
2 8 
* p <0.05, ** p <0.001, comparison between '4 hour animals' and 
'6 hour animals'. 
Urea cycle amino acids (fig. 9). 
In both groups serum arginine levels had dropped to zero 24 hrs after the 
ischemic period. The plasma arginine levels gradually returned to the initial 
values in all but one of the 4-hour animals, while remaining zero in 6 of the 
7 animals that underwent 6 hours of ischemia. The plasma ornithine and 
citrulline levels increased in both groups but the rise was only significant 
in 6-hour animals. 
Histology (table I) 
In 4-hour pigs a mean of 42% of liver cells showed total necrosis. In 
those who died, more than 50% of the liver cells were necrotic, and in those 
who survived less than 40%. Six hours of ischemia resulted in a mean necrosis 
of 62% (range 49-75%). Necrosis of SO% or more resulted ultimately in hepatic 
coma in 9 out of 13 animals. It should be mentioned that beyond the necrotic 
areas large fields of degenerated hepatocytes were always seen; these cells 
were not included in the quantitative assessment of liver cell necrosis. 
TABLE I. Quantitative assessment of liver necrosis by point analysis of whole 
liver slices. 
4 hrs of liver ischemia 6 hrs of liver ischemia 
survival(hrs) % necrosis survival(hrs) % necrosis 
animal no 72 15 20 70 
2 26 68 20 66 
3 10 67 29 49 
4 72 34 72 50 
5 72 36 50 50 
6 72 34 43 75 
7 6 + 30 69 
8 51 + 
+ no histology available. 
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Discussion 
Our experiments show that ischemia of the liver in fully ambulant 
normothermic pigs was often tolerated for 4 hours, but that 6 hours of 
hepatic ischemia was usually followed by hepatic coma and death. Previous 
studies (6) had failed to identify the minimum ischemic period required to 
produce hepatic coma in non-anesthetized pigs mainly because of poor 
reproducibility. Our results, however, confirm several recent reports (9,10) 
that the normothermic liver appears to be more resistant to ischemia than 
previously appreciated. 
Except for the duration of transient hepatic ischemia other factors may 
influence the effect of hepatic ischemia on survival. Anesthesia with its 
variations in duration and depth and the variable metabolic disturbances 
associated with surgery may modulate the extent of liver damage and thereby 
the final outcome (5). Therefore, in contrast to most previous studies (7-10) 
we induced transient hepatic ischemia in the pig after the effects of 
anesthesia and surgery had disappeared. 
The time interval between initial surgery and the induction of liver 
ischemia is said to influence the extent of liver cell necrosis due to the 
formation of collaterals (6,14). Since we had nearly always observed 
encephalopathy and death due to massive necrosis of the liver in earlier 
experiments with non-surgical induction of permanent hepatic ischemia (15), 
we have continued to use a time interval of three days between initial 
surgery and the non-surgical induction of hepatic ischemia. A potential 
source of collateral circulation in a model based on transient ischemia is 
the wall of the common bile duct. This structure contains a network of blood 
vessels which can supply an appreciable amount of blood to the liver. 
Therefore a short piece of tubing was placed in the common bile duct and the 
blood flow along the common duct was interrupted by two ligatures around the 
tube ends. 
Another factor that could affect liver cell necrosis and thus the duration 
of tolerable liver ischemia is the putative toxins that appear in the 
anhepatic state. Extensive bowel cleansing before induction of hepatic 
ischemia and an adequate supply of calories afterwards were included in our 
protocol in an attempt to minimize the disturbances of the 'internal milieu'. 
30 
Is this an adequate model of acute hepatic failure? The requirements for a 
satisfactory animal model of acute hepatic failure, as compiled by Terblanche 
(4), include l. potential reversibility, 2. reproducibility, 3. death due to 
hepatic coma after elapse of a ti~e period sufficiently long to allow hepatic 
support procedures to be instituted, 4. the use of a large animal, 5. 
induction of liver necrosis without biohazard. 
!.Reversibility. Since hepatic circulation is restored in our model 
(albeit only through the hepatic artery), the potential for recovery and 
regeneration is present. Histologically 6 hours of hepatic ischemia resulted 
in necrosis less than 75% of the liver cells. None of the animals had a 
totally (90-100%) necrotic liver. Therefore, at least 25% of the liver tissue 
remained available for recovery and possibly regeneration, assuming that the 
majority of cells in various stages of degeneration retain the potential of 
recovery in a normal ' internal milieu' (17,18). 
2.Reproducibility. All animals subjected to 6 hours of ischemia developed 
severe encephalopathy (EEG grade 4) within 30 hours and died within 20 to 50 
hours, except for one animal that survived for 72 hours. The histological 
data showed necrosis of 50-75% of the liver and all biochemical measurements, 
including analysis of putative toxins were fairly uniform. The variations in 
observations which are inherent to any biological experiment appear less 
prominent in our model than in most models for drug-induced acute hepatic 
failure (19 ,20). 
3. Death from liver failure. Within 30 hours all animals that underwent 6 
hours of hepatic ischemia developed severe encephalopathy (EEG grade 4) which 
was followed by death. In two animals l:lver failure was complicated by 
gastric hemorrhage that resulted in early death. With respect to this 
complication, stress induced by insufficient freedom of movement might be of 
pathogenetic importance in this animal species. Endotoxemia and bacteremia 
were excluded as non-hepatic causes of death in our earlier studies (16). The 
time between induction of ischemia and the development of encephalopathy and 
death is about 24 and 48 hours respectively; such a period is sufficiently 
long for introduction of an experi.mental treatment and evaluation of its 
effects. 
4. Other requirements for an appropriate animal model are the use of a 
large animal and minimal hazards to the personnel. In our model highly inbred 
pigs were used. The model of hepatic ischemic necrosis does not require the 
use of dangerous toxic substances. 
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We think therefore that our animal model fulfills all the criteria 
proposed (4) for an appropriate animal model of fulminant hepatic failure. 
Several other interesting observations with regard to this animal model 
were made. 
1. Clinical 
measurements was 
neurological assessment by 
of restricted diagnostic 
means of semi-quantitative 
value 
non-coma from coma. In contrast EEG assessment 
and distinguishes only 
identified all grades of 
encephalopathy in pigs with ischemic hepatic necrosis. Automated EEG analysis 
showed that objective measurement of encephalopathy in pigs is feasible (data 
will be published elsewhere). 
2. Hepatic ischemia for 6 hours did not in itself induce marked 
abnormalities in coagulation tests. However, as soon as revascularization of 
the ischemic liver was established severe disturbances developed. A marked 
drop in platelet count and in the levels of fibrinogen and other clotting 
factors was observed, suggesting intravascular coagulation. Exposure of the 
blood to damaged sinusoidal cells within the ischemic liver seems a likely 
explanation for the observed findings (21). No reduction in platelet counts 
was observed in earlier experiments in pigs with permanent ischemia of the 
liver who showed a decrease in the levels of the clotting factors to 20% at 
24 hours (15,22,31). 
3. Tyrosine and phenylalanine ratio 1 s clearly increased in our model. 
Elevation of the tyrosine ratio was greater for the 6-hour animals and 
therefore seems to be related to the degree of hepatic insufficiency (23-27). 
Correlations between the degree of liver cell necrosis and other amino acids 
ratio's were not found. Assuming that disturbances in the transport of amino 
acids across the blood-brain barrier are best expressed by plasma ratio's, 
tyrosine appears to be the major abnormality of neutral amino acids in 
hepatic encephalopathy in the pig. These observations contrast with the 
findings in rats and dogs of a concurrent rise of tyrosine, phenylalanine and 
tryptophan. 
4. Associated with the liver failure was a decrease in plasma arginine 
levels of more than 90%. In animals who survived the plasma arginine levels 
normalized while they remained zero in those tvho died. Arginine is required 
for effective utilization of ammonia in the urea cycle (28). A correlation 
between the persistent absence of plasma arginine and the rapid rise in 
ammonia may be entertained. However, the observations (29,30) that 
arginase is released from the necrotic liver cells into the plasma 
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compartment, and induces conversion of plasma arginine into ornithine and 
urea (a rise in plasma ornithine levels was indeed observed, fig.lO), 
emphasizes the need for measurements of intracellular concentration of 
arginine before inferences about the activity of the urea cycle can be made. 
In conclusion we believe that our animal model of acute hepatic failure is 
comparable to the human condition of acute hepatic failure. Since the model 
is reversible as well as reproducible and does not constitute a biological 
hazard, it can be used for studies of the pathogenesis and complications of 
acute liver failure. Moreover, since our model utilizes a large animal with a 
life expectancy of about 48 hours, testing of hepatic support systems or 
assessment of auxiliary liver transplantation procedures is possible. 
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Abstract 
Objective measurement of hepatic encephalopathy by means of spectral 
analysis of the EEG, visual evoked potentials (VEP) and brain stem auditory 
evoked potentials (BAEP) was studied in pigs with ischemic hepatic necrosis. 
The mean dominant frequency (NDF) and the relative power of the delta 
frequency band (% power) showed significant changes with increasing 
encephalographic grades of encephalopathy: MDF dropped from 7.0 ± 0.5 Hz 
(grade 0) to 2. 7 ± 0.3 Hz (grade 3 encephalopathy) and % power increased 
from 52± 7% (grade 0) to 83 ± 6% (grade 3). 
The patterns of the VEP in pigs corresponded to those of the human VEP. 
However, significant differences in either latency time of the peaks or the 
peak amplitude with increasing stages of hepatic encephalopathy could not be 
found. The BAEP registered for pigs were reproducible but also were not as 
useful as spectral analysis for grading hepatic encephalopathy. 
Running title: Spectral analysis and evoked responses in hepatic coma. 
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Introduction 
Pigs are often used to study the pathogenesis or treatment of hepatic 
encephalopathy, because of their physiological similarity with the human 
being. Reliable methods for the objective measurement of encephalopathy in 
pigs are non-existent. Clinical neurological assessment 
encephalopathy in pigs is subjective and unreliable, since 
of the grade of 
it yields only a 
distinction between coma and non-coma. Conventional EEG readings have been 
proposed as a method fo1· grading hepatic encephalopathy ( 1, 2, 3, 4), but 
interpretation of the results remains subjective and therefore dependent on 
the experience and consistency of the electroneurologist. 
The introduction of quantitative analysis of the EEG offered the 
possibility of measuring hepatic encephalopathy objectively (5,6) _ By this 
method the EEG can be expressed in terms of the mean dominant frequency 
(H.D.F.) and the wave amplitude as a function of the frequency (power 
spectrum). Recently evoked potentials were introduced as another objective 
test for hepatic encephalopathy (7-ll). 
The present work was carried out to determine the reliability of 
quantitative EEG analysis and evoked potentials as a means of grading pigs 
with hepatic encephalopathy. 
Haterial and Methods 
Surgical 
used. Pigs 
preparation. Fifteen large White 
underwent laparotomy for the 
pigs, weighing 28 to 33 kg, were 
introduction of a functional 
end-to-side portocaval shunt. All ligaments and peritoneal attachments to the 
liver were cut or coagulated. Subsequently a clamp was placed around the 
isolated hepatic artery. Five silver electrodes ( ¢ l mm) were inserted 
through the skull onto the dura for the recording of the EEG and evoked 
potentials: two over the frontal cortex, one in the vertex and two over the 
occipital cortex. 
cement (Surgical 
The electrodes were anchored with sterile acrylic bone 
Simplex, Howmedica, London,England) and channeled 
percutaneously. Three days after construction of the portocaval shunt acute 
hepatic necrosis was induced by temporarily tightening the clamp to close off 
the hepatic artery for 4 or 6 hours. Anesthesia was not used in this phase, 
since it may interfere with subsequent neurological assessments. Glucose (12 
g/kg/24 hrs), penicillin G (9 megaU/24 hrs) and kanamycin (3 g/24 hrs) were 
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infused continuously. The environmental temperature was maintained at 25°C to 
ensure normothermia of the pigs with hepatic necrosis. 
Recording procedure. During the study periods the animals were placed in a 
dim room on their left side and covered with a sheet to ensure adequate 
relaxation. EEG recordings were taken before induction of hepatic necrosis 
and 24, 30, 48, 52 and 72 hrs afterwards. It should be noted that pigs as 
soon as they tend to fall asleep have an 1 abnormal' slow EEG. Therefore in 
order to obtain a meaningful EEG they had to be aroused each time. The 
potentials in four bipolar leads (left and right fronto-occipital, 
frontofrontal and occipita-occipital) were registered by an EEG apparatus 
(Ahrend v.Gogh, Amsterdam, Holland). During 3 'epochs' of 100 seconds the 
signals of the fronto-occipital leads were stored simultaneously on a 
magnetic tape (Analog 7, Philips, Eindhoven, Holland) for (quantitative) 
spectral analysis. The EEG channels were filtered with a band pass filter 
between 0.5 Hz and 70 Hz. The stored data were fed into a computer (PDP 
11/34) at a sampling rate of 51.2 Hz and a sensitivity of 11 bits/5V. Each 
epoch of 100 seconds was divided into 10 periods. The power spectrum (the sum 
of wave amplitudes as a function of each frequency or frequency band) was 
calculated for each period of 10 seconds using the Fast Fourier 
Transformation, and the mean power spectrum for each 100-second epoch was 
obtained. The frequency resolution was 0.1 Hz. To minimize the effect of 
artefacts, only the range of 1.0-25.6 Hz was used to calculate the mean 
spectrum which was then analyzed (fig.1). 
The parameters calculated were the mean dominant frequency and the 
relative power of the delta, theta and alpha frequency range (12). The mean 
dominant frequency (MDF) was
0
defined as~ 
(fi= frequency i, 
MDF= ~i/Si/ zsi 
i""l i=l Si=power of frequency i, n= the number of frequencies). 
The delta activity was defined as the activity of the frequencies 1.0-3.5 HZ, 
the theta activity that of the frequencies 3.5-8.0 Hz, the alpha activity 
that of the frequencies 8.0-13.0 Hz, and the beta activity that of the 
frequencies 13.0-25.6 Hz. The 3 epochs of 100 seconds were averaged. Spectra 
that showed high muscle activity in the beta frequency band or asymmetry 
between the two fronto-occipital leads were not included in the calculations. 
The EEG recordings were analyzed independently by an experienced 
electroneurologist; the 5 grade classification system described by Opolon 
(2,4) was used. 
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fig.1a,b. A visual representation of the EEG power spectrum (sum of all 
amplitudes as a function of the frequency) for normal pigs (a) and 
for pigs with hepatic encephalopathy (b), 
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Visual evoked potentials (VEP). A photo stimulator with a xenon flashlight 
provided stimuli with a flash intensity of 1 J and a stimulation frequency of 
1 Hz. The experiments were performed in a darkened room with the flashlight 
at a constant distance of 70 em from the right eye. The EEG, monitored on an 
oscilloscope and on the EEG recorder, was stored on the magnetic tape during 
a 300-second artefact-free period. For the two fronto-occipital leads VEP 1 s 
were obtained by averaging the response of 100 stimuli. Only the responses 
during the first 400 msec were used (13). 
Brain stem evoked potentials (BAEP). Responses from electrodes at the 
vertex and ear lobes were recorded. Ten clicks/sec were generated; the 
intensity of each click was 70 dB and it lasted 0.2 msec. Clicks were 
presented to the animal via an earphone. The average response in the 10-msec 
interval after the stimulus (n=2000) was calculated by computer (PDP 11/34). 
Each animal was subjected to two mono-aural tests in a 5 minute period. 
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Data evaluation. Analysis of the VEP in normal pigs showed 7 waves 
(fig.2a). Peaks I,III,V and VII were positive, whereas peaks II,IV and VI 
were negative. All peaks occurred within 150 msec after visual stimulation. 
Analysis of the BAEP in pigs showed 5-6 positive waves within the first 6 
msec (fig.Ja). 
All waves found for normal animals were compared with the waves found for 
animals with hepatic encephalopathy. Horeover each animal was used as its own 
control during the development of encephalopathy. The latency time was 
defined as the time (msec) between onset of the stimulus and the maximal 
amplitude of each peak. Amplitudes between two consecutive positive . and 
negative peaks were measured, 
fig.2a. 
b. 
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Results 
Survival. 
Fifty percent of the pigs undergoing four hours of ischemia of the liver 
survived. Two animals died from complications (air embolism, peritonitis) and 
2 of hepatic coma. Six hours of ischemia was followed by hepatic 
encephalopathy in all animals. Four of the 7 animals died of hepatic coma; 
one animal in hepatic coma, grade 4, was sacrificed after 72 hours and two 
other animals had concurrent gastric hemorrhage. 
EEG and spectral analysis (fig.4,5). 
The EEG, semiquantified into grades l-5, gradually deteriorated after 
induction of ischemia. Animals subjected to 4 hours of ischemia developed 
mild encephalopathic EEG changes whereas 6 hours of ischemia produced severe 
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The course of the EEG grades for pigs that have undergone 4 hours 
and 6 hours of ischemia of the liver. 
' 
' 
' 
' 
' 
EEG-grades 
Spectral analysis data for pigs with various EEG grades of 
encephalopathy, expressed as the mean dominant frequency (MDF) 
(mean ± SD) and the relative percentage of the delta power 
(mean± SD). The differences between grades 0,1,2 and 3 were 
significant (p ( 0.01). 
encephalopathic EEG changes within 30 hrs. 
The mean dominant frequency dropped significantly with each grade of 
encephalopathy up to grade 3. No significant frequency differences were 
observed between grade 3 and grade 4 encephalopathy. 
The relative power of the delta activity was 52 ± 7% in grade 0, and this 
increased significantly with each grade of encephalopathy up to grade 3 (83 ± 
6%). Delta activities for grades 3 and 4 did not differ significantly. An 
example of the power spectra for grade 0 and grade 3 encephalopathy is given 
in fig.l. 
VEP (table I). 
The latency time for all peaks was measured during several grades of 
encephalopathy. The overall results did not show significant differences in 
peak latency or changes in amplitude between grade 0 and grade 4 
encephalopathy. However, in some animals there was an increase in latency 
time of peak VII and an decrease in amplitude between peak IV and V during 
encephalopathy (fig.2b). 
TABLE l. VEP peak latency times (msec, mean ±SD) in relation to the grade 
of encephalopathy. 
peaks 
I II III IV v VI VII 
encepha~ 
lopathy 
grade 0 33 ± 8 40 ± 5 54 ± 6 82 ± ll 107 ± 18 133 ± 25 154 ± 17 
31 ± 2 36 ± 5 52 ± 9 82 ± 19 101 ± 15 1!6 ± 16 151 ± 10 
2 24 35 ± 5 49 ± 7 76 ± 14 103 ± 12 125 ± 12 143 ± 15 
3 24 38 54 ± 6 89 ± 17 122 ± 27 131 160 
4 ++ 36 ± 4 48 ± 9 ++ ++ ++ 153 ± 34 
++ no definite peak discernable. 
BAEP (table II). 
As a rule the five positive peaks could be identified during all grades of 
encephalopathy. The latency times and amplitudes of the five peaks did not 
change significantly with the grade of encephalopathy (fig.3b). 
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TABLE II. BAEP peak latency times (msec, mean ±SD) in relation to the grade 
of encephalopathy. 
peaks 
A B c D E F 
encepha-
lopathy 
grade 0 1.4 ± 0.1 2.2 ± 0.2 2.8 ± 0.2 3.5 ± 0.2 4.4 ± 0.2 5.6 ± 0.3 
1.4 ± 0.1 2.2 ± 0.2 2.6 3.5 ± 0.1 4.2 ± 0.3 5.5 ± 0.3 
2 1.3 ± 0.1 2.0 ± 0.2 2.6 ± 0.1 3.4 ± 0.3 4.2 ± 0.3 5.6 ± 0.3 
3 1.5 ± 0.2 2.2 ± 0.1 2.6 ± 0.2 3.4 ± 0.1 4.4 ± 0.2 5.9 ± 0.5 
4 1.4 ± 0.1 2.0 ± 0.2 2.5 ± 0.1 3.4 ± 0.2 4.1 ± 0.3 5.5 ± 0.4 
Discussion 
Since clinical grading of hepatic encephalopathy in pigs is subjective and 
difficult, Opolon et al (4) introduced 5 grades of encephalopathy based on 
conventional EEG recordings. However, the interpretation of the EEG remains 
subjective and dependent on the expertise of the observer. Our study showed 
that objective measurement of 
means of spectral analysis. 
hepatic encephalopathy in pigs is possible by 
The EEG activity, represented by the mean 
dominant frequency, exhibited a fairly close correlation with the grade of 
encephalopathy. The relative power of the delta band expressed as a 
percentage of the total power of the alpha, beta, theta and delta bands, 
increased significantly with deterioration of the EEG, reflecting an increase 
in slow wave activity. Although the mean values of MDF and % delta power were 
significantly different for each grade of encephalopathy, individual 
measurements showed some overlapping. Therefore both parameters should be 
used together to classify the grade of encephalopathy, although our results 
indicate that a reliable distinction between grades 3 and 4 encephalopathy 
was not possible. 
VEP's in pigs have the seven main components present in man (13). However, 
the reproducibility of "!:he latency times and the amplitudes of two 
consecutive positive and negative peaks for each grade of encephalopathy was 
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rather poor. In some individual animals we observed a decrease in amplitudes 
of two consequence positive and negative peaks and an increase in the latency 
time of peak VII. That VEP constitutes a sensitive procedure to measure 
hepatic encephalopathy in pigs could not be confirmed, in contrast to the 
optimistic results obtained with rats and rabbits (7,8), 
The BAEP's were measured to obtain information about the conduction time 
in the brain stem during hepatic encephalopathy. In contrast to VEP's BAEP's 
were highly reproducible. Five well-defined peaks could be obtained even in 
coma (grade 4). However, significant changes in the latency times of any of 
the peaks were not detected during progression of the hepatic 
encephalopathy. 
In conclusion, objective measurement of hepatic encephalopathy in pigs by 
means of spectral analysis of the EEG is possible. Evoked potentials, 
however, are not sufficiently sensitive to follow the course of hepatic 
encephalopathy in pigs. 
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ABSTRACT 
The incidences of endotoxemia and bacteremia were evaluated in 30 pigs 
with ischemic hepatic necrosis that were treated by hemodialytic procedures. 
Prior to induction of hepatic ischemia, ten pigs underwent bowel cleansing by 
means of an oral dose of magnesium sulfate and 20 received a combination of 
magnesium sulfate and lactulose. 
Endotoxemia and bacteremia seldom occurred during the development of 
hepatic encephalopathy, but the incidence of both increased markedly shortly 
before death. Pigs pretreated with magnesium sulfate and lactulose however 
did not develop preterminal endotoxemia. A significant relation between 
endotoxemia or bacteremia and survival was not found, irrespective of 
pretreatment with lactulose. Of the positive limulus tests, 67% were 
accompanied by a positive blood culture, while 42% of all positive blood 
cultures ivere associated with a positive limulus test. Dialysis with 
dialysates contaminated with endotoxins did not increase the risk of 
endotoxemia. 
It is concluded that in an animal model of ischemic hepatic necrosis (1) 
endotoxemia and bacteremia appear mainly in the preterminal stage but do not 
influence the duration of survival significantly;(2) lactulose prevents 
endotoxemia and (3) dialytic procedures do not increase the risk of 
endotoxemia and bacteremia. 
Key-words: Endotoxemia and bacteremia Ischemic hepatic necrosis 
Hemodialytic treatment - Prevention with lactulose. 
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Introduction 
Endotoxemia is said to be a common feature of acute hepatic falure and has 
been suggested to be a major cause of death for anhepatic animals (1,2). 
Endotoxemia has therefore to be excluded as an interfering event in animal 
model used for the study of hepatic encephalopathy. We used the model of 
ischemic hepatic necrosis for our studies on the efficacy of hemodialytic 
procedures in acute liver failure (3). To validate our model we studied the 
incidence of endotoxemia and bacteremia during the development of 
encephalopathy, and in particular the effect of hemodialysis, which might 
increase the risk of endotoxemia and bacteremia because of contaminated bath 
water (4,5). Since it has been suggested that lactulose may have an 
endotoxin-reducing effect in liver disease (6, 7) we followed two bowel 
cleansing protocols to evaluate the efficacy of lactulose in the prevention 
of endotoxemia in our animals. 
Methods 
Animals: In 30 large White pigs, 8-10 weeks old and weighting 25-30 kg, a 
portocaval shunt was constructed and a loose silicone loop placed around the 
hepatic artery and common bile duct. Two days later, one day before the 
induction of ischemic hepatic necrosis by tightening the silicone loop, bowel 
cleansing was performed. The first 10 animals received 30 g of magnesium 
sulfate via a gastric tube, the last 20 animals were given 150 ml of 
lactulose in addition to the magnesium sulfate. Immediately after induction 
of ischemic hepatic necrosis all animals received glucose (9kg/24 hrs), 
penicillin G (9 M units/24 hrs) and kanamycin (3 g/24 hrs), intravenously. 
Hemodialytic procedures were started 18 hrs later, as described previously 
(9). Twelve animals underwent AN69 hemodialysis with a polyacrylonitrile 
(AN69) membrane (Rhone Poulenc, Paris, France), 4 cross-hemodialysis, 5 
hemofiltration with reinfusion of an electrolyte solution and 5 
hemofiltration with reinfusion of autologous ultrafiltrate. Four animals did 
not undergo any extracorporeal procedure. 
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Neasurements. The duration of survival was defined as the period between the 
induction of ischemic hepatic necrosis and the time of death. 
Blood samples for bacterial cultures and the endotoxin assays were taken 
before induction of ischemic hepatic necrosis, 14 and 24 hrs later and just 
before death. Blood was drawn under sterile conditions from the arterial end 
of the Scribner shunt. Dialysate was collected for bacterial cultures and the 
endotoxin assays at the end of each dialysis period. 
Endotoxin assay. Glass tubes with covers (Kimax) \vere cleansed by rinsing 
with distilled, pyrogen-free water and 96% w/v alcohol. After autoclaving at 
180°C for 2 hrs the covers were placed on the glass tubes and both were 
autoclaved at 180°C for 3 hrs. Four ml of blood were collected in a Kimax 
tube containing 100 U of heparin. After centrifugation at 800 g for 10 
minutes, l ml plasma was transferred to another Kimax tube and stored at 
-25~C until assayed. After thawing, 0.1 ml of plasma was diluted 10 times 
with 0.9% NaCl. The mixture was boiled for 2 minutes and than allowed to cool 
to room temperature. In the test procedure, equal volumes (0.1 ml) of the 
solutions to be tested and limulus lysate (Pyrogent; Hallinckrodt/Byk, 
Netherlands) were mixed in sterile, pyrogen-free 10 mm x 75 mm glass test 
tubes, and incubated in a water bath at 37°C for 24 hours. The formation of a 
firm gel, which could be inverted twice Hithout breaking, Has considered t1 
positive test. This assay has a detection limit of 0.060 ng of endotoxin per 
ml of plasma or dialysate. Positive and negative controls Here run with each 
test. Plasma of a healthy volunteer with 0.12 ng of endotoxin per ml was used 
as the positive control, pyrogen free water and 0.9% NaCl were used as 
negative centrale. 
Bacteriology. Blood samples were cultured in 60 ml of Trypticase soy broth at 
37°C and observed for two days. In the event of bacterial growth, a 
subdivision was made for the culture of aerobic bacteria. Dialysate was 
cultured in Brewer's thioglycolate medium and on McConkey agar; after an 
incubation period of 24 hours subcultures were made. 
Results 
Endotoxins. Two of the 30 animals (7%) had a positive limulus test before 
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induction of ischemic hepatic necrosis. At 14 hrs, 4 animals had a positive 
test, endotoxemia persisted in these animals until death. At 24 hrs, the 
incidence of endotoxemia did not increase. However, 6 of 16 animals (38%) 
developed endotoxemia preterminally (Table 1). A association between survival 
time and endotoxemia was not observed. Animals with endotoxemia did not die 
sooner than animals without a positive limulus test (Table 2). 
Blood cultures. Three of the 30 animals (10%) had positive E.coli cultures 
before induction of ischemic hepatic necrosis; the cultures remained positive 
during the 'anhepatic' state. At 24 hrs, a slight increase in the number of 
positive blood cultures was observed. However, preterminally and coincident 
with the increased incidence of endotoxemia, there was a marked increase in 
the number of positive blood cultures to 59% of all animals. E.coli, 
Enterobacter and Klebsiella were the bacteria most frequently isolated (Table 
1), An association between survival time and positive blood cultures could 
not be detected (Table 2). 
Endotoxemia and bacteremia. Combined analysis of all blood cultures (n:::74) 
and endotoxin (n:::74) showed that of the 12 animals with a positive limulus 
test, 8 also had a positive blood culture (67%). 
Negative blood cultures (n=55) were associated with a positive limulus 
test in only 4 cases (7%). Nineteen positive blood cultures were accompanied 
by 8 positive limulus test (42%) and 11 negative limulus tests (58%). A 
negative endotoxin assay did not exclude bacterial invasion, since 11 of the 
62 samples (18%) with a negative limulus test showed bacterial growth. 
Effect of hemodialysis on endotoxemia. In nine cases, all animals undergoing 
closed-circuit hemodialysis, the dialysate contained both bacteria and 
endotoxins. The predominant microbe in the dialysate was identified as 
Pseudomonas aeruginosa, except in one case in which E. coli was the main 
bacterium. The endotoxin concentration in all dialysates exceeded 0.5 ng/ml. 
All blood cultures and limulus tests were negative before dialysis (Table 3). 
At the end of the procedure one animal had a positive blood culture (e.coli) 
accompanied by a positive blood culture (e.coli) accompanied by a positive 
limulus test. 
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" TABLE 1. 
Incidence of endotoxemia and bacteremia in ischemic hepatic necrosis. 
Endotoxin Blood culture Endotoxin + blood culture 
hrs of ischemia N pos % N pas % N pos % 
0 30 2 7 30 3 10 30 0 0 
14 28 4 14 27 6 22 27 2 
preterminal (32-64) 16 6 38 17 10 59 16 6 38 
TABLE 2. 
Effect of endotoxeroia and bacteremia on survival of pigs with ischemic 
hepatic necrosis treated by hemodialytic procedures. 
no of animals survival time* 
(hrs) 
Endotoxin pos 6 47.7 ± 12. 0 
neg 15 48.6 ± 13. 1 
Blood culture pas 12 49.3 ± 13.0 
neg 9 45.8 ± 9.0 
* survival time is expressed as mean± 1 S.D. 
12 animals with hemodialysis, 4 with cross dialysis, and 5 with 
hernofiltration with reinfusion of an electrolyte solution. 
TABLE 3. 
Bacteriological findings before and after hemodialysis of pigs with ischemic 
hepatic necrosis. 
Blood (n:=9) 
before dialysis 
after dialysis 
Dialysate (n=9) 
after dialysis 
endotoxin 
pos 
0 
9 
neg 
9 
8 
0 
culture 
pos 
0 
9 
neg 
9 
8 
0 
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Effect of bowel cleansing. Bowel cleansing with lactulose and magnesium 
sulfate markedly affected the incidence of endotoxemia (Table 4). Out of a 
total of 48 blood cultures and endotoxin assays in the lactulose group, 7 and 
2 samples, respectively, were positive in the non-lactulose group of 26 blood 
cultures and endotoxin assays 12 and 10, respectively, were positive. Of the 
animals that did not receive lactulose, 75% had a positive limulus test 
preterminally, while none of the animals pretreated with lactulose had a 
positive limulus test at that time. The survival time of animals treated with 
lactulose 'tVas 51 ± 11 hrs which does not differ significantly from that of 
animals without lactulose pretreatment (45 ± 12 hrs). 
TABLE 4. 
Incidence of endotoxemia and bacteremia in relation to bowel cleansing for 
pigs with ischemic hepatic necrosis. 
pos.blood culture 
pos.endotoxin 
MgS04, no Lactulose 
N~10 
time after ischemia 
0 14 preterminal 
3 8 
* 3 6 
Lactulose + MgS04 
N"20 
time after ischemia 
0 14 preterminal 
2 3 2 
1 0 
* only 8 of the 10 preterminal blood samples were available. 
Discussion 
Our results confirm the high incidence of bacteremia (60%) in acute 
hepatic failure described by others (1), but the incidence of endotoxemia was 
lower (38%) than that described by Wilkinson (8) in humans, and by Grlin and 
Liehr (9) in rats with a galactosamine-induced hepatitis. In general 
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endotoxemia and bacteremia developed in our model preterminally; the 
incidence did not increase markedly during the development of hepatic 
encephalopathy . Gans et al (1,2) proposed a direct effect of bacteremia and 
endotoxemia on the survival of anhepatic dogs; in our model of ischemic 
hepatic necrosis we found no evidence for an effect of endotoxemia on 
survival. In fact, we found no clinical difference between endotoxin positive 
and endotoxin-negative animals. During ischemic hepatic necrosis all animals 
developed a similar progressive and ultimately severe encephalopathy with a 
flat EEG shortly before death. 
A pronounced correlation between a positive limulus test and a positive 
blood culture of endotoxin-related microbes was found. A positive limulus 
test and a negative blood culture was only seen sporadically (7%). From our 
data we conclude that a blood culture remains the most simple and sensitive 
method for detection of bacteria or bacterial products in acute experimental 
liver disease. 
Our data suggest that an AN69 polyacrylonitrile membrane is not permeable 
to either bacteria or endotoxins. Eight of the 9 animals had a negative 
limulus test after dialysis. The one positive endotoxin test can be explained 
by the positive blood culture containing E.coli. These data confirm the 
observations of Bernick (10) who demonstrated the absence of endotoxins in 
plasma after dialysis with contaminated dialysate. The conflicting data 
presented by Tobin (11) and Raij (4) are based upon their experience with 
Kill and other non-disposable dialysers with design defects; this, together 
with faulty sterilization, can result in direct contamination of the blood 
compartments with endotoxins. AN69 hemodialysis, however, seems to be safe, 
since it does not increase the risk of endotoxemia. 
The interesting effect of lactulose plus magnesium sulfate on the 
incidence of bacteremia and endotoxemia can be explained by the bowel clean-
sing effect of these drugs which results in a diminished number of 
endotoxin-producing gut bacteria. Liehr et al. (7) proposed a direct anti-
endotoxin effect of lactulose. The effect of lactulose on endotoxemia in men 
with liver disease has been described by Magliulo (6) and Scevola (12). The 
latter obtained positive limulus tests for 9 patients with acute hepatitis, 8 
with cirrhosis, 1 with hepatic coma and 1 with chronic persistent hepatitis; 
after treatment with lactulose and paromomycin 18 of the 19 patients had a 
negative endotoxin assay. Our experimental results confirm these clinical 
observations. The implications of this finding in particular on survival and 
57 
other endotoxin-related complications, however, remain unclear. Further 
investigations into the use of lactulose to reduce endotoxin mediated 
symptoms in hepatic failure are warranted. 
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Abstract 
We studied the duration of survival and the removal of putative toxins in 
forty pigs with ischaemic hepatic necrosis, undergoing haemodialysis or 
cross-dialysis with a large-pore membrane. Ischaemic hepatic necrosis was 
induced in conscious animals by tightening a loop around the hepatic artery 3 
days after construction of a portocaval shunt. Pigs treated by a dialysis 
procedure survived significantly longer (45.2±11.9h) than controls 
(26.3±5.4h). There was no difference between haemodialysis and 
cross-dialysis. 
Blood ammonia initially dropped significantly (p < 0.05) more during 
haemodialysis (560±107-.:,.210±51 umol/1) than during cross-dialysis (596±131-i> 
398±81 umol/1) but it subsequently increased beyond initial values despite 
efficient removal during continuous dialysis. Removal of ammonia was greater 
during cross-dialysis than during haemodialysis, but haemodialysis was more 
effective in the removal of the ammonia precursors glutamine and urea. 
We conclude that dialysis procedures can prolong survival in pigs with 
ischaemic hepatic necrosis. The removal of ammonia-precursors is more 
effective in the prevention of hyperammonaemia than the removal of ammonia 
itself. Since dialysis cannot prevent progressive hyperammonaemia, control of 
excessive toxin production seems mandatory for effective hepatic support. 
Key words: acute hepatic insufficiency, haemodialysis, 
ammonia. 
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cross-dialysis, 
Introduction 
Various extracorporal liver-support systems have been used in acute 
hepatic failure. However, exchange blood transfusions, cross-circulation, 
total body washout, charcoal-haemoperfusion, haemodialysis and 
cross-haemodialysis are in general not considered acceptable because of the 
side-effects and/or insufficient efficacy in relation to the complexity of 
the procedure. 
Recently, haemodialysis with a large-pore polyacrylonitrile (AN-69) 
membrane was described as a relatively simple procedure with promising 
efficacy. Reversal of electroencephalographic abnormalities was observed in 
animal experiments (1), and over 50% of the patients with acute hepatic 
failure and grade IV coma regained consciousness (2), but the effect on 
survival is as yet uncertain (1-3). 
The aim of our investigation was to study the effect of AN-69 membrane 
dialysis on the survival of pigs with ischaemic hepatic necrosis. In 
addition, we studied the capacity of large-pore membrane dialysis techniques 
to remove free- and protein-bound toxins, since a limited toxin removal 
capacity could have been the major cause of the failure of previous hepatic 
support systems. Thirdly, in order to test the hypothesis that deficiencies 
of liver-dependent factors play a role in hepatic failure, we compared 
haemodialysis with cross-dialysis: in haemodialysis toxins are removed, while 
in cross-dialysis it is possible that -in addition to toxin removal-
deficient factors will be transferred from the normal animal to the anhepatic 
animal. 
Material and methods. 
Animals 
Forty Large White pigs, 8-10 weeks old and weighting 25-30 kg, were used. 
Anaesthesia was induced by intramuscular injections of ketamine chloride 20 
mg/kg and after endotracheal intubation maintained with Fluothane 0. 6-0.8 
vol% and N20/02 (2:1). 
Pigs undenvent laparotomy for construction of a functional end-to-side 
portocaval shunt. All ligaments and peritoneal attachments to the liver were 
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cut or coagulated. Subsequently, a loose silicon loop was placed around the 
isolated hepatic artery and the common bile duct, and all other structures in 
the hepato-duodenal ligament were severed. A Scribner shunt was inserted, 
connecting the carotid artery to the jugular vein. 
Three days after the construction of the portocaval shunt and 1 day after 
cleansing of the bowel with 25 g of magnesium sulphate, acute ischaemic 
hepatic necrosis was induced by tightening the loop around the hepatic 
artery. Anaesthesia was not used in this phase, since it may interfere with 
the subsequent neurological assessments. Pigs were placed in restraining 
cages, in order to avoid unnecessary suffering of the animals. Glucose (12 
g/kg/24h), penicillin G (9 mega-U/24h) and kanamycin (3 g/24h) were infused 
continuously. The environmental temperature was maintained at 25°C to ensure 
normothermia in the pigs with ischaemic hepatic necrosis. 
Experimental design 
For the first series of experiments dialysis procedures were performed 
once for a 6 hr period, starting 18 h after ischaemic hepatic necrosis was 
induced. Each week three pigs were prepared: two animals with an open 
Scribner shunt were selected by an independent laboratory technician for 
either haemodialysis or cross-dialysis, while the third animal served as a 
control. Finally the haemodialysis group comprised six animals, the 
cross-dialysis group six animals and control group seven animals (two animals 
died shortly after surgery due to technical complications). 
For the second series of experiments, dialysis procedures were continued 
24 h a day for as long as the pig remained alive, up to a maximum of 60 h 
after ischaemic hepatic necrosis was induced. At the end of this series, the 
continuous haemodialysis group, the cross-dialysis group and the control 
group each comprised seven animals. 
Haemodialysis (fig.la). 
Pigs undergoing haemodialysis were connected to a disposable AN-69 
haemodialyser (Rhone Poulenc, Paris, France) primed with 300 ml of 0.9% NaCl. 
Blood from the arteriovenous Scribner shunt was pumped through the 
haemodialyser at the rate of approximately 150 ml/min, as measured by an 
electromagnetic flowmeter. Initially, only four of the sixteen compartments 
of the haemodialyser were used (to prevent circulatory collapse); every 10 
min additional compartments were opened until complete utilization of all 
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compartments was achieved within 1-2 h. A closed circuit 751 Rhodia! 
Apparatus (Rhone Poulenc, Paris, France) was used as dialyser. The dialysate 
flow was maintained at 500 ml/min, and the temperature at 38°C. The 
+ + + 
composition of the dialysate was Na 140 mmol/1, K 3 mmol/1, Mg 0. 75 
mmol/ 1, Ca ++ 1. 5 mmol/ 1, C1- 113 mmol/1, acetate 35 mmol/1, and glucose 4 
mmol/1. During continuous haemodialysis, the dialysate was changed every 6 
hrs. Anticoagulation was achieved by systemic administration of heparin; 
after a priming dose of 3000 IU, heparin was continuously infused at the rate 
of approximately 1000 IU/h in order to obtain a two-fold prolongation of the 
recalcification time. 
an hepatic 
pig 
an hepatic 
pig 
HEMODIALYSIS 
AN 69 
A 
v 
200 ml/min 500 ml/min 
CROSS DIALYSIS 
A 
v 
200 ml/min 
AN 69 
v 
A 
250 ml/min 
75 I 
dialysate 
sheep 
Fig.l. A schematic flow-diagram of the haemodialysis and cross-dialysis 
procedures. 
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Cross-dialysis (fig.lb) 
Pigs undergoing cross-dialysis were connected to the disposable AN-69 
haemodialyser as previously described. Normal animals •·1ere used as donors; 
they were connected to the dialysis compartment of the AN-69 haemodialyser in 
exactly the same fashion as the animals with ischaemic hepatic necrosis. For 
the donor, the blood flow was maintained at 250 ml/min, and the temperature 
at about 38°C. Anticoagulation of the donor's blood was induced by continuous 
infusion of heparin at a rate of 1500 IU/h, after a priming dose of 10,000 
IU. 
Measurements 
Duration of survival was defined as the period between induction of 
ischaemic hepatic necrosis and time of death. All animals for the 6 h series 
and the series with continuous dialysis procedures were monitored in an 
identical way. The temperature, blood pressure, heart rate and response to 
various stimuli, such as pain and sound, were assessed every 6 h. Blood for 
biochemical analysis was collected every 6 h in ice-chilled plastic tubes 
containing disodium EDTA; within 20 min the plasma was separated by 
centrifugation at 4°C. After storage at -20°C for a maximum of 72h, 
deproteinization was performed by ultrafiltration (Amicon centriflow 
membranes CF25) at 4°Cj the ultrafiltrate was frozen at -20°C until analysis. 
Ammonia was measured by an enzymatic method using glutamate dehydrogenase 
according to da Fonseca Wollheim (4). Glutamine and urea were also determined 
enzymatically by measuring the increase in the ammonia concentration after 
addition of glutaminase (5) or urease (6), respectively. Bile acids and total 
bilirubin in plasma were determined by a fluorimetric method (7) and the 
method of Jendrassik & Gr6f (8), respectively. 
+ + -Blood glucose electrolytes (Na , K , Cl ) , total protein , pH, p02 and 
pco2 , platelets and clotting factors are the prothrombin complex (Normotest 
Nyegaart, Oslo, Norway) were measured by standard laboratory techniques. 
Blood samples were cultured in 60 ml of trypticase soy broth at 37°C and 
observed for 1 week. 
Calculations 
The measurements of ammonia, urea and glutamine were corrected for 
variations in plasma dilution induced by the haemodialysis procedures as 
follows: 
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Measured concentration (tn) x 
t
0 
prior to the start of a 
total protein (t
0
) 
total protein (tn) 
dialysis procedure 
tn n hours after the start of a dialysis procedure 
The formulas for removal and clearance are: Removal=(A-V)xflow=umol/min; 
clearance"" (A-V) flow/ A=ml/min; where A=calculated arterial concentration of 
substance, and V""calculated venous concentration of the substance, 
Statistical methods included Student's t-test and Wilcoxon rank sum test for 
unpaired samples (9). 
Results 
Adequacy of the model 
After induction of ischaemic hepatic necrosis all forty pigs (see Table I) 
showed neurological changes, including drowsiness and decreased responses to 
sound and pain, but no animal was completely comatose (no reaction to sound 
and pain). The temperature varied between 36.8 and 38.6°C for the majority of 
animals; preterminal hypothermia developed in six animals. All blood cultures 
were negative except one (E.coli); there were only minor variations in the 
levels of the electrolytes and blood gases. Blood glucose ranged between 5.2 
and 15.4 mmol/1 (mean ±SD 8.0±3.6); hypoglycaemia ( ( 2.5 mmol/1) was never 
observed. Clotting factor values varied between 20% and 30% (mean ±SD: 29% ± 
8; normal ) 75%) 18 h after ischaemic hepatic necrosis, and between 10% and 
20% 24 h after ischaemic hepatic necrosis. Prior to the start of dialysis, 
plasma ammonia was markedly elevated in all animals (mean ±SD: 569±110 
umol/1, normal (70). Post-mortem examination showed completely necrotic 
livers with the exception of a small area around the inferior vena cava. No 
statistical differences were observed for these features between the 
haemodialysis group, the cross-dialysis group and the control animals (Table 
1) . 
Survival 
For fourteen control pigs, survival after induction of ischaemic hepatic 
necrosis was 26.3±5.4 h. Pigs undergoing dialysis procedures (n=26) survived 
significantly longer (45.2±11.9 h, p < 0.05) than the control pigs. There was 
no significant difference in survival between haemodialysis and 
cross-dialysis, nor between a single 6 h dialysis procedure and conti~uous 
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* Table 1. Clinical and biochemical data for pigs 18 h after induction of 
ischaemic hepatic necrosis, immediately prior to dialysis. 
Response to pain 
Heart rate (beats/min) 
Systolic blood pressure (mmHg) 
Body temperature {"C) 
Blood pH 
Blood cultures, positive 
Blood glucose (mmo1/ 1) 
Blood NormotestR (%) § 
Plasma ammonia (umo1/1) 
Plasma glutamine (umo1/1) 
Plasma urea (mmo1/ 1) 
Serum bilirubin (umo1/1) 
Serum bile acids (umol/1) 
* Mean ± SD. 
+ Number of experiments. 
++ Data from three animals. 
Haemodialysis Cross-dialysis Controls 
(13)+ (13) (14) 
+ + + 
102±25 98±20 100±28 
95±10 108±15 100±12 
37.8±0.7 38.2±0.4 37.0±1.4 
7.51±0.02 7.50±0.03 7.46±0.08 
0 0 0 
8.0±4.1 8.0±3.7 8.0±3.2 
27±9 29±6 29±9 
560±107 596±131 560±93 
752±230 640±186 1000±467 
0.8±0.2 0.7±0.2 1,0±0.3 
12±8 8±4 13(8-15)++ 
1035±208 1134±288 1140(920-1250)++ 
The Norrootest measures the joint of the factors II, VII, X on the 
coagulation and is expressed as % of normal according to the manufacturer 
Nyegaard & Co (Oslo). 
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dialysis procedure. Pigs treated by continuous dialysis procedures had a 
prolongation of survival, but all animals ultimately died during 
extracorporal treatment and none had their life maintained by dialysis 
procedures (Fig.2). 
Complications affecting survival were not observed in either the control 
group or the animals undergoing 6 h dialysis. In contrast, hypotension C< 80 
mmHg) and intraperitoneal bleeding occurred in five out of fourteen animals 
during a continuous dialysis procedure (haemodialysis three, cross-dialysis 
two); in the majority of cases these complications occurred beyond 42 h of 
dialysis. All donor-animals survived the extracorporal procedures without 
untoward effects; some donors were used for 3 consecutive weeks. 
80 
• 
70 
• 
60 
• 
.; • 
~ 50 • _c • 
• • • • 
..L • • 0 40 • -. > 
I • • > : • ~ • 
" •I ~ 30 • • • 
•• • 20 •• • • 
10 
controls hemodialysis c rossd i a I ys is 
Fig.2. Survival after ischaemic hepatic necrosis for controls (N ~ 14), 
pigs undergoing haemodialysis for 6 h (e, N ~ 6) and continuously 
(x, N ~ 7) and pigs undergoing cross-dialysis for 6 h (&, N = 6) 
and continuously (x, N = 7). 
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Freely diffusible toxins 
Eighteen hours after induction of ischaemic hepatic necrosis, blood 
ammonia was markedly elevated (569:!:110 umol/1). After the first 6 h of 
haemodialysis the blood ammonia had dropped to 210:!:51 umol/1 whereas it 
increased to 699±199 umol/1 in the control animals (Fig.J). The decrease in 
blood ammonia after 6 h was significantly (p ( 0 .05) less with cross-dialysis 
(398:!:81 umol) than with haemodialysis. In contrast, cross-dialysis removed 
significantly (p < 0.05) larger quantities of ammonia per minute than 
haemodialysis (Table 2). In spite of persistently efficient ammonia removal, 
dialysis 
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procedures could not prevent a subsequent rise in blood ammonia; at 
values corresponded to those of the control group (Fig.4). 
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Fig.J. Blood ammonia (mean :!: SD) and blood glutamine concentrations in 
pigs with ischaemic hepatic necrosis during haemodialysis (o, N 6) 
and cross-dialysis (e, N = 6) and without dialysis (controls) 
(o,N~t4). 
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* Table 2. Removal of putative toxins (in umol/min) by continuous dialysis 
from pigs with ischemic hepatic necrosis. 
Haemodialysis+ 
1 h 6 h 12 h 24 h 
Ammonia 20 15 20 15 
Glutamine 49 71 103 90 
Urea 30 30 34 34 
Bile acids 3.3 4.1 ++ 3.6 
Bilirubin 1.0 2. 1 1.2 2.0 
* (A-V)xflow. 
+ Mean value of seven experiments. 
++ Deleted because of erratic measurements. 
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Fig.4 Blood ammonia concentrations (mean ± SD) in pigs with ischaemic 
hepatic necrosis during continuous haemodialysis (o, N = 7) and 
cross-dialysis (e, N = 7), 
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The blood glutamine concentrations were not significantly affected by 
dialysis. For both groups undergoing dialysis, the rise in the level of 
glutamine parallelled that of the control group (Fig.3), although appreciable 
quantities of glutamine were removed. Haemodialysis removed about twice as 
much glutamine as cross-dialysis (Table 2). 
The levels of blood urea were low but within the normal ranges 18 h after 
induction of ischaemic hepatic necrosis. Haemodialysis produced a significant 
decrease in blood urea concentration from 785±258 umol/1 to 334~108 umol/1 at 
6 h. In contrast, the blood urea levels rose during cross-dialysis to 3 times 
the initial values (2705~840 umol/1 at 6 h). In the control animals the blood 
urea concentration did not change significantly (Fig.5). The quantity of urea 
removed by haemodialysis was significantly greater than that removed by 
cross-dialysis; in fact, in cross-dialysis a flux of urea from the donor 
animal to the animal with ischaemic hepatic necrosis was found (Table 2), 
....J 
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Fig.S. Blood urea concentrations in pigs with ischaemic hepatic necrosis 
during haemodialysis (o, N = 6) and cross-dialysis (e, N ~ 6) 
and without dialysis (controls), (o, N = 14). 
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Protein-bound substances 
The concentration of bile acids in serum decreased slowly from 1084±248 to 
680±248 umol/1 at 24 h. while serum bilirubin rose from 10±6 to 100±20 
umol/1; no differences were observed between haemodialysis and cross-dialysis 
as far as the blood levels of protein-bound molecules are concerned (Fig.6). 
The removal of bile acids and bilirubin was low compared to that of freely 
diffusible molecules (Table 2). 
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Fig.6. Blood bilirubin (mean ± SD) and bile acid concentrations (mean 
± SD) in pigs with ischaemic hepatic necrosis during continuous 
haemodialysis (o,N 7) and continuous cross-dialysis (e, N = 7) 
and without dialysis (o, N = 7). 
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Discussion 
Both haemodialysis and cross-dialysis significantly prolonged the survival 
of pigs with ischaemic hepatic necrosis. In the past, the experiments by 
Opolon et al. (1) had only shown improvement in EEG recordings, but no effect 
on the duration of survival. A possible explanation for the discrepancy 
between effect on encephalopathy and survival was early mortality due to 
post-operative complications. We therefore chose a mode with a delay between 
the surgical trauma and the induction of hepatic failure. We have no reason 
to believe that the prolongation of survival in our experiments was due to 
incomplete devascularization of the liver. In fact, ammonia levels were 
markedly increased and the clotting factors were found to be below 30% in all 
pigs. Our results confirm the observations of Wallin and coworkers, who also 
demonstrated prolongation of survival with haemodialysis and cross-dialysis 
in hepatectomized dogs (10). However, in their series of experiments, as well 
as the present study, the control group was not selected by a randomization 
procedure; therefore we do not exclude the possibility that some of this 
effect on survival was due to selection. In our series, however, analysis of 
factors possibly affecting survival, such as temperature, positive blood 
cultures, elevation of blood ammonia and depression of clotting factors, did 
not show differences between the control group and the groups undergoing 
dialysis (Table 1). 
The reason for the beneficial effect of dialysis remains unclear. Opolon 
(11) supports the middle molecule hypothesis since he did not find any 
improvement with cuprophan dialysis. We were surprised by the significant 
decrease in blood ammonia during haemodialysis and the lack of an appreciable 
drop during cross-dialysis. At first sight, this finding does not support the 
theory that ammonia plays a role in acute hepatic coma, but it should be 
noted that at 24 h hyperammonaemia was of equal magnitude for the two groups 
on dialysis and the premortal values did not differ from those of the 
controls. 
Initially, ammonia removal apparently exceeded ammonia production since 
blood levels decreased. After 6-12 h, however, rising blood ammonia 
concentrations were observed despite constant ammonia removal, pointing to 
increasing ammonia production. Increased ammonia production in animals 
undergoing cross-dialysis is the only logical explanation for the lack of an 
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appreciable drop in blood ammonia, since removal of ammonia was excellenr:. 
One of the mechanisms by which ammonia production might be enhanced during 
cross-dialysis is transfer of an ammonia precursor to the animal with 
ischaernic hepatic necrosis. The levels of urea are higher in donor animals 
than in pigs 18 h after induction of ischaemic hepatic necrosis. This 
gradient induces a flow or urea from the donor to the pig with ischaemic 
hepatic necrosis, where urea apparently is converted to ammonia. 
Therefore the removal of precursors of ammonia might be as important as 
the removal of ammonia itself in the treatment of hyperammonaemia. To express 
the removal of ammonia plus ammonia precursors we used the formula: removal 
of ammonia + 2x (removal of glutamine) + 2x (removal of urea)=total amount of 
ammonia equivalents removed. \~e assume that 2 moles of ammonia are taken up 
for the synthesis of mole of either urea or glutamine (Table 3). In 
haemodialysis, the removal of ammonia equivalents amounted to 238 umol/min, 
while in cross-dialysis it was significantly less (113 umol/min, p(O.OS) due 
to the inferior removal of glutamine and urea. Thus the less pronounced 
decrease in the blood ammonia concentration during cross-dialysis can be 
explained. 
x 
Table 3. Removal of ammonia equivalents§ 
(in umol/min) by continuous dialysis 
from pigs with ischaemic hepatic 
necrosis. 
++ Haemodialysis 
++ Cross-dialysis 
* (A-V)xflow. 
Hours 
6 12 
176 221 291 
37 124 157 
Ammonia + (glutamine)x2+(urea)x2. 
++ Mean value of seven experiments. 
24 
261 
136 
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The concept of cross-dialysis is attractive because of the combination of 
toxins removal and supply of deficient factors. However, since no difference 
in prolongation of survival was observed between haemodialysis and 
cross-dialysis, we have not found any support for the hypothesis that 
deficient factors are responsible for hepatic encephalopathy. In contrast, we 
now have evidence that untoward metabolic effects can occur, such as the 
transfer of the ammonia precursor urea. These side-effects may out-weigh the 
potential benefits of supply of deficient factors so that in our opinion 
cross-dialysis procedures have no advantage over simple haemodialysis 
procedures with exclusively removal of toxins. 
Protein-bound substances were removed rather ineffectively by both 
dialysis procedures. The presence of albumin on the dialysate side of the 
membrane in cross-dialysis did not increase the removal of molecules 
predominantly bound to albumin, as could be expected from a theoretical point 
of view. Still the concentrations of the protein-bound substances showed 
marked variations in relation to their production. Bile acids with their 
exclusive hepatic synthesis decreased appreciably during 24 h, while 
bilirubin with its non-hepatic origin rose. 
We measured bile acids and bilirubin as markers for putative protein-bound 
toxins. Since concentrations of these markers in animals treated by a 
dialysis procedure were similar to those in controls, we think it is unlikely 
that removal of protein-bound toxins could be responsible for the observed 
prolongation of survival by dialysis. 
Dialysis for 6 h was a procedure practically devoid of side-effects, in 
contrast to continuous dialysis; the latter was associated with hypotension 
and haemorrhagic diathesis. The increases incidence of complications can 
partly explain the absence of further prolongation of survival with 
continuous dialysis. From a theoretical point of view, Berk ( 11) suggested 
that an extracorporal procedure carried out twice a day for 4 h provides the 
maximum benefit in relation to efforts and risks; on the basis of our data it 
also seems worthwhile to evaluate treatment with alternating 4-6 h periods on 
and off dialysis. 
In conclusion, haemodialysis is effective in prolonging survival in 
functionally anhepatic pigs, but life cannot be maintained by haemodialysis 
at present. The beneficial effect of haemodialysis could be due to removal of 
ammonia and ammonia-precursors, but other factors as well might be involved. 
The failure of continuous haemodialysis to sustain life of anhepatic animals 
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seems primarily related to the inability to correct biochemical 
abnormalities. Accelerated toxin production rather than decreased removal of 
toxins during haemodialysis in hepatic support can be expected if a more 
effective haemodialysis procedure can be combined with measures which prevent 
excessive toxin production. 
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Abstract 
In order to define further the therapeutic role of hemodialytic procedures 
in acute hepatic failure, 20 pigs with ischemic hepatic necrosis underwent 
via randomization hemodialysis against an electrolyte solution (n ~ 6, bema-
filtration with re-infusion of an electrolyte solution (n S),control 
hemofiltration with re-infusion of autologous ultrafiltrate (n ~ 4) or no 
extracorporal procedure at all (n ~ 5). 
Pigs on hemodialytic procedures survived significantly longer (51 ± 11 
hrs) than controls (36 ± 8 hrs). There were no differences in the duration of 
survival between hemodialysis and hemofiltration, nor between controls 
undergoing and those not undergoing an 
Electroencephalograms showed more rapid (p ( 0.05) 
animals than in the treatment group. Putative 
extracorporal procedure. 
deterioration in control 
toxins such as ammonia, 
glutamine, tyrosine, tryptophan,and methionine all decreased transiently in 
the treatment group; in the control group a continuous increase in the levels 
of the putative toxins was observed. 
Comparison of all pigs surviving 35 hrs or less (n = 6) and animals 
surviving more than 45 hrs (n 7) showed that long-term survival was 
significantly associated with lower plasma ammonia and methionine 
concentrations and fewer abnormalities on the electroencephalogram 10 hrs 
after the start of extracorporal procedures; moreover six of the 7 long-term 
survivors underwent hemodialysis or hemofiltration procedures. 
He conclude that hemodialytic procedures prolong survival in pigs Hith 
ischemic hepatic necrosis by slowing the development of encephalopathy; this 
effect of hemodialytic procedures may be mediated by the lowering of plasma 
ammonia and methionine levels. 
Keywords: acute hepatic insufficiency, hemodialysis, hemofiltration, ammonia, 
methionine, electroencephalogram. 
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Introduction 
The acute hepatic failure syndrome is generally thought to be caused by 
accumulation of several toxins normally metabolized by the liver. 
Hemodialytic techniques in particular those using large-pore membranes have 
been proposed as a therapeutic device; however its effects in acute hepatic 
failure have not as yet been precisely defined (1-3). Reversal of 
electroencephalographic abnormalities and correction of brain 
neurotransmitter imbalance were reported by Opolon and co-workers (2,4) but 
no improvement in the duration of survival was observed. In contrast we found 
prolongation of survival in an irreversible model of acute hepatic 
insufficiency in pigs (5). Neither these studies nor the clinical studies 
reported to date (6,7) were of the randomized controlled type. In addition, 
only limited neurofysiological and biochemical measurements could be 
performed in our first study. It therefore remained unclear how the 
prolongation of survival was brought about by the hemodialytic procedures. 
The aim of this investigation was to perform a randomized study comparing 
animals with ischemic hepatic necrosis undergoing large-pore hemodialysis 
with an adequate control group; the main goal was to study the effect on the 
duration of survival and on the neurologic state which was objectively 
monitored by means of an electroencephalogram. In addition, within the group 
undergoing large-pore hemodialysis we compared the effect of two variants of 
this technique: dialysis with a closed circuit dialysate, and hemofiltration 
which has a superior clearance for substances of 'middle molecular' size than 
hemodialysis (8). We also investigated by which mechanism the beneficial 
effects of these extracorporal procedures were obtained. 
Material and methods 
Animals Twenty 30-35 kg healthy White pigs underwent laparotomy for 
construction of a functional end-to-side portocaval shunt. All ligaments and 
peritoneal attachments to the liver were cut or coagulated. Subsequently, a 
loose silicon loop was placed around the isolated hepatic artery and common 
bile duct, and all other structures in the hepato-duodenal ligament were 
severed. A Scribner shunt was inserted, connecting the carotid artery to the 
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jugular vein. Two days after the construction of the portocaval shunt the 
bmvels were cleaned with 30 g of magnesium sulfate and 150 ml of lactulose 
(50% w/v), to suppress excessive hepatic coma toxin production in the gut. 
One day later ischemic hepatic necrosis was induced acutely by tightening the 
loop around the hepatic artery without anaesthesia. Subsequently, in order to 
provide adequate nutritional support glucose (10 g/kg/24 hrs) and amino acids 
( 1. 3 g/kg/24 hrs, Aminosteril Hepa 8%, Fresenius, Germany, composition in 
g/1: Isoleu 10.4; Leu 13.9; Lys 6.88; Meth 1.1; Cyst 0.52; Phen 0.88; Thr 
4.4; Tryp 0.7; Val 10.8; Arg 10.7; His 2.8; Gly 5.82; Ala 4.64; Ser 2.24; 
Acetic acid 7 .25), mixed in one bottle, were infused continuously. Each 
bottle also contained penicillin G (9 mega U/24 hrs), kanamycin (3 g/24 hrs) 
as well as sodium, potassium and phosphate supplements (8 mmol/24 hrs, 37 
mmol/24 hrs and 45 mmol/24 hrs, respectively). The environmental temperature 
was maintained at 25°C to ensure normothermia in the functionally anhepatic 
pigs. 
AN-69 hemodialysis (Fig.1) Pigs undergoing AN-69 hemodialysis were 
connected to a disposable large-pore polyacrylonitrile (AN-69) membrane 
hemodialyzer (Rhone Poulenc, Paris, France) primed with 300 ml of 0.9% NaCl. 
Blood from the arteriovenous Scribner shunt v1as pumped through the 
hemodialyzer at a rate of approximately 200 ml/min, as measured by the 
air-bubble technique. Initially, only 4 of the 16 compartments of the 
hemodialyzer were used to prevent circulatory collapse; every 10 minutes 
additional compartments were opened until all compartments were in use. 
A closed circuit 75 1 Rhodia! Apparatus (Rhone Poulenc, Paris, France) was 
used as dialysis machine. Dialysate flow was maintained at 500 ml/min and the 
temperature at 37°C. In this system the clearance of substances, which is 
dependent on molecular size, amounts to approximately 90 ml/min for ammonia 
(MW 17) and 60 ml/min for amino acids (MW 75-204) according to previous 
experiments (5). 
The composition of the dialysate was Na+ 135 mmol/1, K+ 3 mmol/1, Mg++ 
0.85 mmol/1, Ca++ 1.0 mmol/1, Cl 110 mmol/1, lactate 5.0 mmol/1, 
bicarbonate- 28.0 mmol/1 and glucose 4 mmol/1. Anticoagulation was achieved 
by regional heparinization. After a priming dose of 750 IU, heparin was 
infused continuously into the arterial blood line prior to its entry into the 
dialyzer at a rate of 101JO IU/hr (""10 rog/hr); similarly protamine chloride 
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\vas infused continuously into the blood leaving the dialyzer at a rate of 12 
mg/hr. 
an hepatic 
pig 
HEMODIALYSIS 
AN 69 
500 ml/min 
HEMOFILTRATION 
751 
dialysate 
micro~ processor 
' ~-...-~ 
Fig 1. Schematic flow diagram of AN-69 hemodialysis and 
hemofiltration procedures. 
Hemofiltration (Fig.1) Pigs undergoing hemofiltration were connected to a 
disposable large-pore cellulose tri-acetate hemofilter (Sartorius, Gottingen, 
Germany) primed with 75 ml of 0.9% NaCl. The cellulose tri-acetate membrane 
is permeable to molecules of up to 15,000-20,000 d; comparable to the AN-69 
membrane, the sieving coefficient starts to fall at a molecular weight above 
5000 d (Fig.2). Blood from the arteriovenous Scribner shunt was pumped 
through the hemofilter at a maximum rate of 500 ml/min. A hydrostatic 
pressure of about 200-300 mmHg was built up in the blood compartment on one 
side of the filter while a negative pressure was created by a second pump on 
the filtrate side of the membrane, leading to an transmembrane pressure of 
approximately 500 mmHg. Under such circumstances 60-80 ml of the 
ultrafiltrate per minute (15 1 in about 4 hrs) are produced. The clearance of 
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all substances with a middle molecular size (up to 5000 d) is equal to the 
quantity of ultrafiltrate formed; i.e. 60-80 ml per minute; the clearance of 
molecules larger than 1500 d is thus superior with this technique than with 
hemodialysis (Fig.2). The ultrafiltrate flows into a barrel which is placed 
on a weight balance. A micro-processor ensures that exactly the same amount 
of substitution fluid (temp. 37°C) is pumped back into the venous line. These 
technical devices are enclosed in one apparatus (Hemoprocessor, type 40005, 
Sartorius, Gottingen, Germany). The composition of the substitution fluid was 
similar to that of the dialysate used in the hemodialysis experiments; it 
+ + ++ ++ 
contained Na 137 mmol/1, K 4.3 mmol/1, Ca 1.0 mmol/1, Mg 0.87 mmol/1, 
lactate 5.0 mmol/1, Cl 115 mmol/1, bicarbonate 27 mmol/1, and glucose 4.0 
rnmol/1. The anticoagulation procedure was exactly the same as that followed 
for the animals undergoing AN-69 hemodialysis. 
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Fig 2. Clearances of substances in relation to their molecular 
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weight for AN-69 hemodialysis (---) • AN-69 hernofiltration 
(- -), and cellulose tri-acetate hernofiltration (----- -), 
the two procedures used in this study. For comparison, data 
are also given for AN-69 hemofiltration, used by Denis et al 
( 8) . 
Control procedures. One group of animals undenvent the ultrafiltration 
procedure described for hemofiltration, the only difference being that the 
animal's own ultrafiltrate was re-infused instead of a commercially prepared 
electrolyte solution. 
The second group comprised animals who did not undergo any extracorporal 
procedure after induction of ischemic hepatic necrosis. 
Experimental design Eighteen hours after ischemic hepatic necrosis was 
induced, the animals were assigned at random to the AN-69 hemodialysis, 
hemofiltration, control (no procedure), or hemofiltration control group. 
Extracorporal procedures lasted 4 hrs and were repeated twice daily, from 
8-12 hrs and from 18-22 hrs, until the animal died or for a maximum of 60 hrs 
after induction of ischemic hepatic necrosis. 
Measurements The duration of survival was defined as the period between 
the induction of ischemic hepatic necrosis and the time of death. 
Electroencephalograms were taken before induction of ischemic hepatic 
necrosis and before and after each extracorporal procedure. Six electrodes 
were placed on the shaved skin of the pig's head and five bipolar tracings 
were recorded on a Beckman apparatus (Accu tracer 110, Beckman, California, 
USA). To prevent low frequency artefacts, the pigs were strapped to a table 
with the eyes covered in a darkened room during electroencephalography. A 
thirthy-five Hertz filter was used to eliminate high frequency artefacts. The 
EEG recordings were analyzed independently by an electroneurologist who was 
not aware of the therapeutic procedures; the 5-grade classification as 
described by Opolon (2) was used. 
Blood for biochemical analysis i.Jas collected before ischemic hepatic 
necrosis was induced and subsequently before and after each extracorporal 
procedure in ice-chilled polystyrene 
centrifugation followed within 20 min at 
tubes containing disodium 
4°C. The plasma was stored at 
for a maximum of 72 hrs, release of ammonia from plasma proteins is 
negligable for this period of time. Deproteinization was then performed by 
ultrafiltration (Amicon centriflow membranes CF 25) at 4°C; the ultrafiltrate 
was kept at -20°C until analysis. 
Ammonia was measured by an enzymatic method using glutamate dehydrogenase, 
according to da Fonseca Wolheim (9). Glutamine and urea were determined 
emzymatically by measuring the increase in ammonia concentration after 
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addition of glutaminase (10) or urease, respectively. Tryptophan and tyrosine 
were measured by a fluorometric method, according to Dencla and Dewey (11) 
and Rochella (12), respectively. Methionine was determined by a modification 
of Collin's method (13), and bile acids by an fluorometric technique 
according to Mashige (14). 
Blood glucose, electrolytes (Na, K, Cl), total protein, bilirubin and 
platelets were measured by standard laboratory techniques; clotting factors 
(R) 
of the prothrombin complex were assayed by the Normotest (Nyegaart, Oslo, 
Norway) method. Blood samples were cultured in 60 ml of Trypticase soy broth 
at 37°C and observed for 2-3 days. 
Calculations and statistics To determine the efficacy of hemodialysis 
procedures the removal of substances was estimated as follows: removal 
(mmol/4 hrs) dialysate concentration (mmol/1) x dialysate volume (L) or 
ultrafiltrate concentration (mmol/1) x ultrafiltrate volume (L/4 hrs). 
For unpaired samples with a normal distribution of data points, the Student's 
t test was used, while the Hilcoxon rank sum test was used in the event of a 
skewed data profile. For comparison within a group, tests for paired samples 
were used. Changes in EEG grades with time were estimated by the linear 
regression method; the value representing the steepness of the curve (0<) were 
used for comparison. 
In additon to comparison of the groups undergoing various therapeutic 
procedures, we also compared animals with a short life span and those with 
prolonged survival. The groups were arbitrarily formed by selecting the 
animals in the upper and lower 33% of the survival range. Differences were 
assumed to be statistically significant when the p-value was less than 0.05. 
Results 
Adequacy of the model Eighteen hours after induction of ischemic hepatic 
necrosis, none of the twenty animals was clinically comatose; the EEG grade 
varied between grades 1 and 2. The temperature of the animals was between 37° 
and 39°C. With two exceptions, blood cultures were negative and endotoxinemia 
absent. Only minor variations in electrolyte levels were seen; blood glucose 
ranged between 5.5 and 14.0 mrnol/1. Clotting factors as measured by 
1 Normotest' were 25% ± 8 (mean ± SD, normal ) 75%) and plasma ammonia was m-
arkedly elevated with a median value of 380 umol/1 (range 192-568) 
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Post-mortem examination showed completely necrotic livers with the 
exception of a small area around the inferior caval vein; one animal in the 
hemofiltration control group with a normal liver both macroscopically and 
microscopically was excluded from further analysis (this animal survived more 
than 60 hrs). 
No statistically significant differences in the initial features (table 
I) were observed between the AN-69 hemodialysis group, the hemofiltration 
group, the hemofiltration control group, and the control (no extracorporal 
procedure) group. 
Adequacy of AN-69 hemodialysis and hemofiltration procedures. Removal of 
substances by AN-69 hemodialysis and hemofiltration are given in table II. 
Both procedures were equally effective in removing the low-molecular 
substances. The efficacy of removal of putative toxins by AN-69 hemodialysis 
was equal to that found in previous experiments in which clearances were 
measured. Clearance in hemofiltration was equal to the quantity of 
ultrafiltrate formed per minute and amounted to 75 ml/min. 
Survival (Fig.3) Pigs undergoing AN-69 hemodialysis or hemofiltration 
survived significantly (p ( 0.01) longer (53 ± ll hrs and 48 ::!: ll hrs, 
respectively) than the control animals that did not undergo any procedure (33 
± 9 hrs). There was no significant difference in survival between AN-69 
hemodialysis and hemofiltration, nor between untreated controls and controls 
on hemofiltration (Fig.3). Since no significant differences were observed for 
any variable (EEG, or biochemical measurements) between AN-69 hemodialysis 
and hemofiltration nor between untreated controls and controls on 
hemofiltration, we combined the data of the AN-69 hemodialysis and 
hemofiltration groups to form the treatment group, and the data of the two 
control groups to form the control group. The duration of survival for the 
treatment groups was 51 ::!: ll hrs and for the control group 36 ± 8 hrs (p( 
0.04). 
Apart from cerebral oedema complications affecting survival were not 
observed in the control group, but intraperitoneal bleeding occurred in 6 out 
of ll animals of the treatment group • particularly in those surviving more 
than 40 hrs. 
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Table I. Clinical and biochemical determinations for pigs before the start of extracorporal procedures, 
18 hrs after ischemic hepatic necrosis. 
* ** HEMDDIALYSIS(6) HEMOFILTRATION(S) HF CONTROLS(4) C0NTROLS(5) 
median range median range median range median range 
Temp,°Celsius 37.7 37-39 38.2 37-39 38.1 35-38 37.0 36-38 
EEG,grades 1-2 1-2 1-2 1-2 
Glucose, mmol/ 7.9 6.2-12.8 7.0 5.5-8.0 7. 1 5. 6-8.1 8.6 6.1-14.0 
Normotest,% 25 17-38 24 12-30 23 20-33 31 16-38 
Fibronogen,g/1 1.7 0.7-1.8 1.7 1.6-2.0 1.1 0.6-1.7 1.7 I .2-1.9 
funmonia, urnol/1++ 347 298-444 341 211-568 438 291-481 396 192-416 
Glutamine, umol/1+ 1140 598-1418 1090 885-1238 1692 80!-2020 1160 630-1409 
Urea, rnmol/ l + 1.6 1.3-2.8 1.4 1.2-2.4 2. I 1.3-2.4 1.7 1.1-2.0 
Tyrosine, umol/1+ 205 129-385 222 148-257 224 176-285 256 230-524 
++ Tryptophan (free),umol/1 50 30-79 49 40-62 40 32-91 57 53-115 
Methionine, umol/1+ 204 169-309 218 !86-244 192 144-280 239 179-417 
Bilirubin, umol/1+ 34 25-101 34 16-107 55 35-72 32 30-50 
Bile Acids, umol/1+ 363 227-999 430 206-556 479 202-968 248 235-952 
* no significant differences between hemodialysis and hemofiltration. 
** no significant differences between hemofiltration (HF) control group and the control group without 
an extracorporal procedure. 
++measured in plasma ultrafiltrate. 
+ measured in plasma. 
Table II. Removal of putative toxins in mmoles (mean ± SD) during 4 hrs AN-69 
hemodialysis and hemofiltration. 
AN-69 hemodialysis Hemofiltration 
(N 20) (N 
Ammonia 7,1 ± 3,8 4,4 ± 
Glutamine 12,4 ± 2,5 18,5 ± 
Urea 150 ± 20 135 ± 
Tyrosine 2,5 ± 1' 0 2,7 ± 
Tryptophan 0,68 ± 0,20 0, 67 ± 
Methionine 1 '9 ± 0,7 2,2 ± 
hours 
70 
•• .. 60 • 
.. 
50 
• 
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• 
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20 
1 0 
HD HF c HFC 
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p < 0.01 
Fig 3. Survival after ischemic hepatic necrosis of pigs undergoing 
AN-69 hemodialysis (HD) and hemofiltration (HF) and 
controls undergoing no procedure (C) and hemofiltration 
18) 
2,0 
10,0 
15 
0, 9 
0,32 
0,6 
with re-infusion of autologous ultrafiltrate (HFC). The bars 
denote median values. 
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Electroencephalogram The means of the EEG grades for the treatment and 
control groups are shown in Fig. 4. The EEG grades gradually became more 
abnormal in the control group; similar but less severe changes were observed 
in the treatment group. After one extracorporal procedure, the grade of the 
EEG abnormalities for the treated animals was already significantly (p (0.03) 
less than that for the controls. 
A linear regression line ~vas constructed using EEG grades at various 
points in time for each animal. The angle presenting the steepness of the 
line was significantly (p <O.OS) larger for the control group than for the 
treatment group, indicating a more rapid deterioration of the EEG in the 
control group. 
A rapid improvement in EEG grading during or immedialtely after 
hemodialysis as reported by Opolon (2) was not observed; on the contrary, EEG 
grades after dialytic procedures were higher than EEG grades prior to 
dialytic procedures (p ( 0.001, paired \.Jilcoxon test). 
EEG grade 
4 
3 
2 
0 18 
* 
22 26 30 34 hrs 
Fig 4. EEG grades (mean± SD) for pigs with ischemic hepatic 
necrosis. Treatment group ( HD+HF, n=ll) o----0, and control 
group (C+HFC, n=9) Ifill a 
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* p ( 0.05, ** p <O.Ol, comparison of treated and control 
animals. 
t7 7 Z 7 /]period of AN-69 hemodialysis, hemofiltration, or 
re-infusion of autologous ultrafiltrate. 
Ammonia After 18 hrs of ischemic hepatic necrosis, the ammonia 
concentration in plasma was markedly elevated: 375 ~ 122 umol/1 (Fig.5). In 
the treated group the ammonia concentrations fell during an extracorporal 
procedure; normalization of ammonia concentrations (below 100 umol/1), 
however, could not be achieved. Between effective extracorporal procedures 
levels of ammonia rose again beyond initial levels. After two extracorporal 
procedures (32 hrs), the plasma ammonia concentration was 370 ~ 160 umol/1. 
In the control group the plasma ammonia concentrations rose progressively to 
615 ~ 193 umol/1. After the first extracorporal procedure, the treatment 
group had significantly (p ( 0.04) lower plasma ammonia concentrations than 
the control group (Fig.S). 
~I<":~~ 
~------------------
>'"'"''' 
'"" 
"" 
'"'~ 
""' 
''" 
pi"'"" gluton'"' 
'"h" 
Fig 5. Plasma ammonia and glutamine (mean ~ SEM) concentrations in 
pigs with ischemic hepatic necrosis. 
Number of experiments and symbols as in Fig 4. 
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Amino acids (Fig. 5 + 6) The plasma levels of tyrosine, glutamine, free 
tryptophan and methionine showed an increase prior to treatment and a 
significant decrease after hemodialytic procedures. Between procedures the 
plasma amino acid concentrations rose to or beyond the initial levels. At 32 
hrs (after two procedures) all amino acid levels were lower than the initial 
concentrations (18 hrs). In the control groups, there was a steady elevation 
of the plasma amino acid levels; as of the 22nd hour these levels were 
significantly (p < 0.03) higher than those found for the treatment group, 
except for free tryptophan. 
~molll 
'"' 
plasma tycosine 
~· 
1GO ------------------
~molll 
"" 
Fig 6. Plasma concentrations of tyrosine, free tryptophan and 
methionine (mean ~ SEM) in pigs with ischemic hepatic 
necrosis. 
Number of experiments and symbols as in Fig 4. 
Short-term survivors and long-term survivors. Animals who survived 35 hrs 
or less were compared with animals surviving more than 45 hrs (table III). 
Eighteen hours after ischemic hepatic necrosis (thus before any procedure) 
the only difference between the two groups was the plasma ammonia 
concentration, which was significantly lower in the long-term survivors. 
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Table III. Biochemical determinations (mean ± SD) for short-term survivors ( ~ 35 hrs) and long-term 
survivors ()45 hrs), 18 and 28 hrs after ischemic hepatic necrosis \Vas induced in pigs. 
18 hrs 28 hrs 
Short-survivors Long-survivors Short-survivors Long-survivors 
(6) (7) ( 6) ( 7) 
X~' 
** Ammonia, umol/1 446 ± 156 273 ± 73 695 ± 143 358 ± 173 
Glutamine, umol/1 1230 ± 530 1l33 ± 437 1646 ± 620 1309 ± 467 
Tyrosine, umol/1 328 ± 149 241 ± 81 397 ± 155 294 ± 46 
Free tryptophan, umol/1 74 ± 31 56 ± 13 77 ± 20 59 ± 21 
* Methionine, umol/1 328 ± 149 241 ± 81 325 ± 116 221 ± 37 
Bilirubin, umol/1 44 ± 15 49 ± 29 71 ± 21 79 ± 31 
Bile Acids, umol/1 571 ± 271 416 ± 218 488 ± 238 413 ± 214 
Normotest,% 30 ± 5 25 ± 6 18 ± 7 17 ± 6 
Fibrinogen, g/1 l. 5 ± 0.5 1.5 :±: 0.3 l.O ± 0.5 1.0 ± 0.2 
Glucose, mmol/1 8.9 ± 2.9 7.7 ± 2.6 10.6 ± 5.4 8.8 ± 4.3 
Urea, mmol/1 l. 7 ± 1.1 1.4 ± 0.4 2. 1 ± 1.4 1. 3 ± 0.8 
,, 
EEG grade 2 ± 0 1.4 ± 0.5 3.5 ± 1.4 2.5 ± 0.5 
Treatment hemodialytic 
** procedures - 1 6 
* 
p (0.05, (short-survivors vs. long-survivors). 
** p(O.Ol 
w 
Twentyeight hours after ischemic hepatic necrosis (6 hrs after the first 
treatment period), plasma ammonia was still significantly (p(0.03) lower in 
long-term survivors and the difference between the ammonia levels found for 
the two groups had increased. Moreover plasma methionine was now 
significantly (p < 0.04) decreased in long-term survivors. The other putative 
toxins did not show significant differences. In addition, at 28 hrs the EEG 
grades were significantly (p (0.02) lower for the long-term survivors, while 
no differences in EEG grades had been noted at 18 hrs. 
Finally, six of the 7 long-term survivors underwent effective extracorporal 
procedures (4 animals on hemodialysis, 2 animals on hemofiltration), while 
none of the 6 short-term survivors received extracorporal treatment. 
Discussion 
In this strictly randomized study with adequate controls, both 
hemodialysis and hemofiltration significantly prolonged survival in pigs with 
irreversible ischemic hepatic necrosis. These findings confirm the 
observations of Wallin and co-workers (1), and our uncontrolled studies on 
hemodialysis and cross-dialysis (5). The prolongation of survival was 
associated with a less rapid development of EEG abnormalities. The beneficial 
effect of hemodialysis on the EEG observed in these experiments was different 
from that described by Opolon, who noted an improvement in the grade of EEG 
during or shortly after hemodialysis. We only observed a slower increase in 
EEG abnormalities in animals treated by hemodialytic procedures, without a 
detectable beneficial effect during the dialysis procedure itself. 
The prolongation of survival and the effect on the EEG could be mediated 
by non-specific effects on body temperature or cerebral edema or by specific 
removal of the cerebral toxins involved in the pathogenesis of hepatic coma. 
Changes in temperature in the treatment group and the controls did not differ 
and a non-specific effect of hemodialysis on cerebral edema -so it be 
present- seems unlikely in view of the decrease in hematocrit and plasma 
albumin during the experiment. 
The comparison of animals surviving less than 35 hrs with long-term 
survivors suggests that ammonia and methionine might be involved in the 
hepatic coma syndrome; we found no evidence that aromatic amino acids, 
tyrosine, and free tryptophan play a significant role in this respect. Other 
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putative toxins such as mercaptans, short chain fatty acids, and GABA were 
not measured and alterations in the concentrations of these substances could 
also explain the prolongation of survival and the delayed deterioration of 
the EEG brought about by treatment. 
The findings on ammonia and methionine are similar to those of the very 
early studies of hepatic encephalopathy (15,16). Ammonia and methionine have 
long been suspected as direct or indirect causes of chronic hepatic 
encephalopathy; our experimental study suggests that these same compounds 
might also be involved in the acute hepatic coma syndrome. No supportive 
evidence was found for the role of 'middle molecules' in the pathogenesis of 
encephalopathy, since duration of survival was not different between 
hemodialysis and hemofiltration, which has a three-fold clearance for 
molecules between 1500-5000 d. 
The difference in survival time between the control animals (26 ~ 5 hrs) 
in our previous experiments (5) and the present controls (35 ~ 8 hrs) is of 
interest; it could be explained by the ammonia lowering effect of lactulose 
given in the present study. In fact, the plasma ammonia levels found for 
control animals were significantly lower in the present study (411 ± 132 
umol/1) than in the previous study (560 ~ 93 umol/1) 18 hrs after induction 
of ischemic hepatic necrosis (5). 
Although dialysis appeared effective in lowering plasma ammonia and 
methionine, it should be stressed that the procedure was unable to achieve 
normalization of plasma ammonia and methionine; in fact even a secondary rise 
in plasma ammonia to initial levels could not be prevented. That the life of 
functionally anhepatic animals cannot be sustained by hemodialysis appears to 
be due to insufficient toxin removal in relation to toxin production as well 
as the bleeding diathesis enhanced by extracorporal procedures. 
Still, the definite prolongation of survival demonstrated in this study 
with an irreversible model of acute hepatic insufficiency justifies further 
evaluation of hemodialysis in potentially reversible model of acute hepatic 
failure. We have recently developed such a model in the pig by applying liver 
ischemia transiently (G. H. de Groot, unpublished observations). Additional 
complications may then arise from the releaSe of products of damaged liver 
cells into the circulation. If bleeding diathesis can be controlled and 
excessive production of toxins prevented, life might be sustained thereby 
providing time for the liver to regenerate. 
93 
References 
1. Wallin W, Turcotte JG, Sloan CH, et al. Conventional and cross-dialysis 
in hepatic failure. Curr Topic Surg Res 1970;2:75-86. 
2. Opolon P, Lavallard MC, Huguet CT, et al. Hemodialysis versus 
cross-dialysis in experimental hepatic coma. Surg Gynec Obstet 1976;142: 
845-854. 
3. Santiago-Delpin EA, Callender C, Kjellstrand CM, et al. Crossdialysis in 
the treatment of experimental fulminant hepatic coma. J Surg Res 1975; 
19:175-182. 
4. Bloch P, Delorme ML, Rapin JR, et al. Reversible modifications of 
neurotransmitters of the brain in experimental acute hepatic coma. Surg 
Gynec Obstet 1978;146:551-558. 
5. Groot GH de, Schalm SW, Schicht I, et al. Comparison of large-pore 
membrane hemodialysis and cross- dialysis in acute hepatic insufficiency 
in pigs. Eur J Clin Invest 1983;13:65-71. 
6. Denis J. Opolon P, Nusinovici V, et al. Treatment of encephalopathy 
during fulminant hepatic failure by hemodialysis with high permeability 
membrane. Gut 1978;19:787-793. 
7. Silk DBA, Trewby DN, Chase RA, et al. Treatment of fulminant hepatic 
failure by poly-acrylonitrile membrane dialysis. Lancet 1977;2:1-3. 
8. Denis J, Opolon P, Delorme ML, et al. Long-term extra-corporal assistance 
by continuous hemofiltration during fulminant hepatic failure. 
Gastroenterol Clin Biol 1979;3:337-348. 
9. da Fonseca Wollheim. Direkte Plasma-Ammoniak Bestimmung ohne 
Enteiweissung. 
Z Klin Chern Biochem 1973;11:426-431. 
10. Stahl A, Frick A, Imler M. Enzymatic micro-assay for blood glutamine. 
Clin Chern 1978;24:1730-1733. 
11. Dencla WD, Dewey HK. The determination of tryptophan in plasma, liver and 
urine. J Lab Clin Med 1967;69:160-169. 
12. Rochella NJ. Automatid fluormetric determination of tyrosine in blood. 
Anal Biochem 1967;21:227-234. 
13. Collins DJ, Robinson R, Knell AJ. Serum methionine: its rapid 
determination by continuous flow colorimetry. Clin Chern Acta 
1978;88:277-281. 
94 
14. Mashige F, Osaga T, Imai K. A simple and sensitive assay of total serum 
bile acids. Clin Chern Acta 1976;70:79-86. 
15. Phear EA, Ruebner B, Sherlock S,et al. Methionine toxicity in liver 
disease and its prevention by chlortetracycline. Clin Sci 1956;15:93-117. 
16. Phillips CB, Schwartz R, Gabuzda GJ,et al. Syndrome of impending hepatic 
coma in patients with cirrhosis of the liver given certain nitrogenous 
substances. N Eng J Med 1952;247:239-246. 
95 

CHAPTER VII 
STRATEGIES FOR HEPATIC SUPPORT IN ACUTE LIVER FAILURE. 
Role of extracorporal devices vs auxiliary transplantation. 
Gerrit H.de Groot 1 , Solko W. Schalm1 , Thomas 
1 2 2 L. Boks , Onno T. Terpstra , Hans Jeekel and 
F . kl 2 1c , Cees B. Reuvers , 
Jacques Bruinvels3 . 
Anton 
1. Department of Internal Medicine II, University Hospital Dijkzigt, 
Rotterdam. 
2. Department of Surgery, University Hospital Dijkzigt, Rotterdam. 
3. Department of Pharmacology, Erasmus University, Rotterdam. 
Supported by the Foundation for Medical Research FUNGO, and the Sophia 
Foundation for Medical Research, the Netherlands. 
Submitted for publication. 
97 
Introduction 
Acute hepatic failure (AHF) is one of the most dramatic situations in 
clinical hepatology, since this syndrome with its high mortality (80-90%) 
usually occurs in relatively young individuals who were previously completely 
healthy (1,2). The poor prognosis is due to the ensuing 1.cerebral edema, 2. 
additional complications and ultimately 3.a lack of liver regeneration. 
Cerebral edema is now acknowledged to be a major cause of death in 
fulminant hepatic failure. Several autopsy studies have found that cerebral 
edema is present in 50%-100% of patients, with up to 20% showing brain stem 
herniation (3-6). The mechanism leading to cerebral edema in AHF is not yet 
fully understood. Alterations in cerebral blood flow due to dysregulation of 
cerebral vascular responses (7,8), hypercapnia and hypoxia (9), lactic 
acidosis (10) and fever are thought to play an additional role in the 
etiology of cerebral edema. There is evidence that cerebral edema is 
characterized by intracellular accumulation of water which can be seen 
microscopically as swelling of the astrocytes (11,12), This cytotoxic type of 
cerebral edema, that can also be seen after hypoxia and in the event of 
intoxication, is associated with inhibition of Na+/K+ dependent ATP-ase 
(13). Some authors suggest that changes in the blood-brain barrier cause the 
cerebral edema (14,15). 
Other lethal complications also occur in patients with AHF. Major 
gastrointestinal hemorrhage contributes to death in 15-20% of the cases 
(6,16,17,18), and bacterial infection has been implicated as a main cause of 
death in 10% (6,19,20). Renal failure, electrolyte abnormalities (21-23), 
acid-base disturbances, respiratory and cardiovascular insufficiency 
(6,8,24,25,26) and hypoglycemia may lead to a fatal outcome. A reduction in 
the number of complications can probably be achieved with continuous and 
extensive monitoring, and intensive care has been claimed to improve the 
prognosis (27,28). 
In the absence of the fatal complications mentioned above, recovery from 
AHF depends on regeneration of the liver or more precisely, on more liver 
regeneration than liver cell destruction. Milandri' s study (29) suggested 
that regeneration of liver cells, assessed by the mitotic index and the 
hepatocyte DNA content, did occur in patients with AHF. However, the rate of 
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regeneration in relation to the rate of liver cell destruction has not been 
quantitatively assessed. 
In view of these reflections, the goals of therapy in AHF should be the 
prevention of cerebral edema and other lethal complications, and the 
stimulation of liver cell regeneration with arrest of hepatic necrosis. The 
rationale for the use of the currently available artificial hepatic support 
systems is to replace the detoxifying function of the liver, i.e. to remove 
the putative toxins. Such devices should help prevent cerebral edema and also 
provide a favorable 'internal milieu' for hepatic regeneration. In the past 
twenty years many reports on succesfull hepatic support systems have 
appeared, but the efficacy of these treatment have never been proved in 
controlled studies nor confirmed by independent groups of investigators (75). 
Moreover, a centre reporting each time about succesfull treatment with plasma 
and heparin, charcoal hemoperfusion and large-pore hemodialysis, ultimately 
receded to early intervention hernoperfusion (76). Results with the latter 
techniques have been impressive in particular for patients with paracetamol 
intoxication or viral hepatitis; the system hmvever was not efficacious for 
acute hepatic failure caused by rifampicin/isoniazid overdose, mushroom 
poisoning or halothane anesthesia. Charcoal hemoperfusion and large-pore 
hernofiltration each have its enthousiastic proponents, but in view of the 
lack or proven benefits also its sceptics. Therefore, in this article we will 
discuss the prospects of artificial hepatic support in acute hepatic failure, 
with emphasis on the efficacy of these artificial systems. 
What should be removed? 
Coma in AHF is thought to be the result of an accumulation of toxic 
metabolites. There are four major hypotheses on the pathogenesis of hepatic 
encephalopathy (30), The first hypothesis states that encephalopathy results 
from the synergistic effects of an excess of ammonia, short-chain fatty acids 
and mercaptanes (31,32), whereas hypoglycemia is thought to potentiate the 
neural inhibition of ammonia and free fatty acids (33). 
The second hypothesis is based on the presence of a plasma-amino acid 
imbalance, increased brain uptake of free tryptophan, phenylalanine and 
tyrosine. An excess production of brain serotonin and octopamine as well as 
depressed synthesis of dopamine and norepinephrine are responsible for the 
disbalance betvJeen inhibitory and excitatory reflexes of the brain (34). An 
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inter-relationship between glutamine and neutral amino acids with regard to 
their passage through the blood-brain barrier and their intracerebral 
metabolism is suspected (34,35). 
The third hypothesis relates to the inhibitory neurotransmitter GABA. It 
has been proposed that increased brain GABA is bound to an increased number 
of GABA receptors in post mortem brain tissue of rats and rabbits, resulting 
in sufficient neural inhibition to produce encephalopathy and coma (36-38). 
The mechanism of increased brain GABA is thought to be either an increased 
uptake or increased synthesis in the brain (39,40). 
The fourth hypothesis originated from observations of the difference in 
the effects of cuprophane membrane and polyacrilonitrile membrane dialysis 
in AHF (41-43). It states that molecules that only pass through the 
polyacrylonitrile membrane 
1000-5000 daltons -the so 
and are characterized by a molecular weight of 
called 'middle molecules'- play a role in the 
pathogenesis of hepatic failure. Recently 'middle molecules' have been 
detected in the sera (15,44,45) and brain (44) of comatose animals and men. 
The uncertainty about the identity of toxins responsible for hepatic 
encephalopathy calls for removal of several classes of molecules, i.e. small 
water-soluble molecules (ammonia, glutamine, mercaptanes, neutral amino 
acids), middle molecules and protein-bound substances. 
What can be removed? 
The accumulation of a wide range of potentially toxic substances of 
different molecular sizes and physical properties suggests that a single 
narrow approach to artificial hepatic support for the treatment of AHF is 
hazardous. At present two techniques have evoked the most interest: 
hemoperfusion 
permeability 
through adsorbents and 
membranes. Adsorbents 
hemodialytic 
allow the 
procedures 
removal of 
using 
free 
high 
and 
protein-bound substances, whereas the dialytic procedures are only effective 
for the removal of free diffusable molecules. Freely diffusable substances 
can be divided into small and middle molecular substances (table I). Markers 
for small molecular substances are urea, ammonia, amino acids, free fatty 
acids and mercaptanes. As markers for the unidentified middle molecules 
vitamin Bl2 and inulin can be used, Bilirubin and bile acids have been 
proposed as markers for protein-bound substances. Bilirubin represents a 
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TABLE I. Removal of putative toxins by hepatic support systems. 
Free diffusable 
Hernodialytic 
procedures 
(large pore membrane) 
small molecular ammonia + 
amino acids + 
phenols + 
free fatty acids +* 
mercaptanes + 
middle molecular vit.B12, insulin + 
Protein-bound 
+ effective removal 
bilirubin 
bile acids 
± some removal of toxins or fast saturation of colurnm. 
no removal 
* personal observations 
Charcoal 
hernoperfusion 
+ 
+ 
+ 
+ 
± 
± 
+ 
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substance produced outside the liver and metabolized by the liver, while bile 
acids represent molecules produced and metabolized by the liver. 
The total removal of toxins is dependent on multiple factors, including 
the amount of blood flowing through the support system per day and the 
clearance capacity of various systems. Table II presents data on blood flow 
through artificial systems and through the normal human liver. The quantity 
of blood passing through hemoperfusion or hemodialytic devices per minute is 
about 10-20% of the normal flow through the liver". Assuming that these 
systems are only in operation for the usual 4 hours per day then 1.6-3.3% of 
the blood flmving through the liver per day passes through the currently 
available clearing devices. 
Extending dialysis-time to 24 hrs per day is feasible, but is associated 
with a markedly increased incidence of side effects (46-50). With regard to 
blood flow, it seems relevant to note that also in regular cross-circulation 
with a systemic-systemic connection, only 3% of the normal daily liver blood 
flow passes through the donor liver during 24 hrs. For, indeed, only 20% of 
the flow through the shunt will pass the donor liver, since liver blood flow 
is one-fifth of the total cardiac output (77). Thus the present available 
artificial organs usually do not have access to more than 3% of the daily 
liver blood flow. 
The clearance capacities of various hemoperfusion (46,51,52) and 
hemodialytic procedures (42,44,46,47), as determined in previous 
investigations as well as from our own studies, are presented in table III. 
Charcoal powder hemoperfusion is the most effective as far as the removal of 
bile acids and some freely diffusable substances, such as amino acids, are 
concerned. Other substances are poorly cleared by hemoperfusion. 
Hemodialysis and hemofiltration exhibit similar clearances for ammonia and 
its main precursors, urea and glutamine; these procedures are superior to 
charcoal hemoperfusion but are less efficient than a normal liver, as deduced 
from the cross-circulation experiments. Clearance of neutral amino acids did 
not differ markedly among the various systems. The clearance of protein-bound 
substances, such as bile acids, by hemodialysis was much lower than by 
charcoal hemoperfusion (table III). 
Thus the currently available artifical hepatic support procedures have in 
general a clearance capacity for putative toxins which ranges from vastly 
inferior to about equal to that of the normal liver. When this is combined 
with the fact that only 3% of the daily hepatic blood flow passes through the 
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TABLE II. Blood flow through hepatic support systems in relation to the normal hepatic blood flow. 
flow flow % of normal hepatic % of normal hepat~y 
1/min 1/24 hrs liver flow/24 hrs liver flow/4 hrs 
Hemodialysis 
Hemoperfusion 0.2 288 13 2.2 
Hemofiltration 0.4 576 27 4.5 
Cross-circulation 
58 1) 2. 7 1) systemic-systemic 0.2 
systemic-portal 0.4 576 27 
In vivo liver flow 1.5 2160 100 
1) flow through the donor liver is about 20% of the shunt flow. 
2) generally regarded as optimal perfusion period as far as both effectiveness and side-effects are concerned. 
TABLE Ill. Clearance by various procedures of substances (ml/rnin) in pigs with hepatic insufficiency. 
N ammonia urea glutamine bile acids tryptophane tyrosine 
AN69 hemodialysis 20 84(60 104) 90(67-115) 58(46-70) 9 (l-16) 40(28-55) 50(27-63) 
Hemofiltration 18 50(45-70) 75(60-95) 54(48-60) 2(1-4) 26(15-37) 55 (38-72) 
Charcoal 
hemoperfusion 12 4(0-38) 10(0-50) 8(0-32) 40(10-123) n.t. 91(31-147) 
Selective ammonia 1 
dialysis 7 85(6-127) 16(0-60) 27(0-67) 6(0-24) n.t n. t 
Cross-circulation 2 304(286-325) 
--
199(151-267) 195(157-257) n. t 82 (77-89) 
(systemic-portal) 
1) In this procedure ammonia is removed directly from a small bathwater circuit by converting ionized 
ammonia to the volatile ammonia which leaves the system via gas-permeable membranes (73, 74). 
n.t.: not tested. 
~ 
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support system, then it seems probable that only 0.03-3.00% of the clearance 
capacity of the normal liver can be replaced by today' s hepatic support 
systems. 
How much should be removed? 
The quantity of toxins that should be removed to correct the 1 internal 
milieu' is dependent on the toxin production rate. In patients with terminal 
renal failure 4 hours of hemodialysis 3 times a week can correct the 
'internal milieu'. This time schedule is based on the production rate of urea 
which is about 100 mmol/day on a low protein diet. In the event of hepatic 
insufficiency the situation appears quite different. Although the exact 
production rate of putative toxins is unknown, it can be estimated in various 
ways. 
Hemodialysis induces a drop in the plasma ammonia and amino acid levels in 
the first hours after initiation of the procedure; subsequently hm..rever the 
plasma levels of ammonia rise again despite a constant rate of removal. 
Apparently initial removal exceeds production, but with time production 
increases in experimental acute hepatic failure (47). Similarly, 
cross-circulation is not capable of sustaining life (54,55), unless a high 
flow system is used (56,57). Here again the production of toxins must lie 
between the removal rates of the normal and the high-flow systems. We have 
used a third method to estimate the production rate of putative toxins. From 
our systemic-portal cross-circulation experiments (arterial blood from animal 
with liver failure flows (400 ml/min) into the portal vein of the donor) we 
calculated the daily capacity of the liver to metabolize putative toxins, 
using the formula: removal/min x 1440 min/day x 3. This latter factor is 
introduced into the formula because the value for removal/min is derived from 
cross-circulation experiments in which only 1/3 of the normal hepatic liver 
flow is processed. We assume that the removal capacity increases linearly 
with flow, since clearance was independent of the plasma concentration of 
putative toxins in our experiments (fig.1)(78). Since we know that life can 
be sustained as long as about 20% of the total liver remains functional, the 
removal capacity required for survival, which will approximate the daily 
production of putative toxins, has been estimated to be 20% of the daily 
removal capacity. In Fig. 2 the capacity of currently available artificial 
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organs, expressed as a percentage of the removal capacity required for 
survival (or the daily production of toxins) , is shown. 
Assuming that the production rates for putative toxins in pigs with acute 
hepatic failure are not markedly higher than those for humans, we may 
conclude that the capacity of the currently available artificial organs is 
probably insufficient to restore the 'internal milieu'. 
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Fig.l. Relation between plasma ammonia concentration and ammonia clearance 
by the normal liver during systemic-portal cross-circulation 
(flow: 400 ml/min). 
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The calculation of these data was based on the results of our 
cross-circulation, hemodialysis and hemoperfusion experiments 
(table III). The minimum removal rate for putative toxins required for 
survival, as calculated from the formula: removal/min x 1440 x 3 x 20% 
(see text), was 69 mmol for ammonia, 17 n®ol for tyrosine, 
and 14 mmol for the protein-bound marker toxin bile acids. 
The removal of ammonia, tyrosine and bile acids by a 4-hour 
hemodialytic procedure was 6.9, 2.4, and 0.9 mmol, respectively. 
For charcoal hemoperfusion these values were 0.1, 8.4, and 3,4 mmol, 
respectively. 
In the figure these data are presented as clearances. Sixteen hours 
of cross-circulation will achieve the 100% clearance needed for 
survival, whereas twentyfour hours of hemodialysis or hemoperfusion 
seem to be insufficient for clearance of the marker toxins ammonia and 
bile acids. 
Perspectives of hepatic support. 
From the data presented it can be concluded that none of the artificial 
systems used at present are sufficiently effective to act as a substitute for 
the detoxification capacity of 20% of the normal liver (table III+ fig.2). 
Hemodialytic procedures and hemoperfusi.on would have to be maintained at 
least 24 hrs/day to stabilize the amino acid levels while anunonia and 
protein-bound putative toxins cannot be corrected during 24-hour treatment 
'"ith the currently available artificial systems. Only systemic-portal 
cross-circulation can take over the detoxification function of 20% of the 
normal liver. The procedure must remain in operation for a minimum of 16 hrs 
per day. However, systemic-portal cross-circulation is not feasible for 
ethical reasons because fatal complications have occurred in donors (55), 
Other means should be found to remove toxins with an effectiveness similar to 
that of systemic-portal cross-circulation. In view of the above 
transplantation of part of a normal liver should lead to restoration of the 
'internal milieu', Blood flow through the transplanted liver will probably be 
larger than in cross-circulation, and the clearance capacity for all putative 
toxins should be similar to that of systemic-portal cross-circt'.lation if the 
transplant is functioning well. The success of this procedure is illustrated 
in figure 3. Seven pigs underwent auxiliary heterotopic transplantation of 
60% of a liver (ATPL). Four days after ATPL and ligation of the portal vein 
to the host liver, acute ischemic necrosis of the recipient liver was induced 
\Vithout surgery by external tightening an occl.uder around the hepatic artery 
for 6 hours (the vessel occluder was positioned at initial surgery). 
Auxiliary transplantation of 60% of the liver sustained life in pigs with 
acute hepatic failure for one month, whereas control animals undergoing 
ischemia of the liver for 6 hours without previous ATPL died within 72 hours. 
Marked changes in the electroencephalogram were not observed in ATPL-animals, 
while controls deteriorated to grade 4 encephalopathy within 48 hours. 
Moreover the synthetic function of the failing liver was adequately taken 
over by the transplanted liver, since clotting factors remained above 50% of 
control values and restored to normal. The excellent metabolic support of the 
partially transplanted liver resulted ultimately in long-term survival in 5 
out of 7 animals (58). 
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Five animals with ATPL survived without showing marked metabolic 
abnormalities. 
Acute hepatic failure was induced non-surgically by transient 
ischemia (59), and auxiliary transplantation of 60% of the liver was 
carried out by the technique of de Jonge (60) and Reuvers, et al(58). 
Conclusion. 
We believe that correction of the 1 internal milieu 1 in acute hepatic 
failure is essential for the prevention of fatal complications and 
regeneration of the diseased liver. Currently available artificial support 
systems are limited by the low flow volume, the duration of treatment and 
clearance capacity. Even if used for 24 hours, the detoxification capacity of 
these systems will still be insufficient, as estimated from our 
systemic-portal cross-circulation experiments. Improvement in the survival of 
patients with acute hepatic failure persisting for several days might be 
enhanced by auxiliary transplantation of part of a liver. Efforts should be 
made to introduce this procedure into clinical practice. 
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CHAPTER VIII. 
SUMMARY AND CONCLUSIONS 
After working for 5 years on the development of methods for the treatment 
of acute hepatic failure (AHF), the following conclusions can be drawn. 
The first purpose of this thesis was to develop an animal model that could 
be considered comparable to the human acute hepatic failure 
secondly, to develop a reliable and objective method for 
cerebral disturbances which are closely associated with 
syndrome and, 
measuring the 
acute hepatic 
failure. Both are necessary for the evaluation of therapeutic modalities for 
acute hepatic failure. 
In chapter II an animal (pig) model for acute hepatic failure that is 
induced by transient ischaemia of the liver is described. Four hours of 
ischaemia were tolerated by 4 out of 8 animals while 6 hours resulted in 
death within 50 hours in 6 of the 7 animals. Severe encephalopathy, which was 
followed by death, developed within 30 hours in all animals undergoing 6 
hours of hepatic ischaemia. With respect to the potential reversibility of 
this model we conclude that 1) hepatic circulation was restored in all 
animals; 2) histological data for all animals undergoing 6 hours of ischaemia 
revealed necrosis of less than 75% of the liver cells. Therefore more than 
25% of liver tissue remained available for recovery and possible 
regeneration. This large animal model for acute hepatic failure fulfills the 
accepted criteria of death by hepatic failure, reproducibility and potential 
reversibility and allows sufficient time to start liver support procedures. 
The disturbed 'internal milieu 1 , as previously described in acute hepatic 
failure, could be confirmed. New interesting data included the plasma amino 
acid pattern during the development of hepatic encephalopathy. The ratio of 
tyrosine to the sum of all neutral amino acids increased markedly and 
correl-1.ted with the degree of hepatic necrosis; the same was found for the 
ratio of phenylalanine. Correlations between the degree of liver cell 
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necrosis and other neutral amino acids ratio's were not found. Assuming that 
disturbances in the transport of amino acids across the blood brain barrier 
are best expressed by plasna ratio's, tyrosine and phenylalanine appear to be 
the major abnormality of neutral amino acids in hepatic encephalopathy in the 
pig. Tryptophane ratio did not change in pigs in contrary to the data found 
in men and rats. Plasma arginine disappeared after induction of ischaemia and 
re-appeared 24 hours later in animals that survived. 
In chapter III methods for objective measurement of hepatic encephalopathy 
are described. The so-called power spectrum a computer-assisted 
transformation of the electroencephalogram - was evaluated since conventional 
EEG readings remain subjective and clinical assessment of pigs is not 
feasible. The power spectrum can be expressed by the mean dominant frequency 
and the relative power spectra of the various frequency bands. The mean 
dominant frequency and the relative power of the delta frequency band were 
sensitive parameters of hepatic encephalopathy up to grade 3. Visual and 
brainstem auditory-evoked responses were neither sensitive nor specific 
indicators of the course of encephalopathy. 
In chapter IV the incidence of endotoxaemia and its influence on survival 
were determined in pigs with permanent ischaemic hepatic necrosis. The 
incidence of endotoxaemia increased markedly before death; endotoxaemia could 
be prevented by the oral administration of magnesium sulfate and lactulose. A 
significant relation between endotoxaemia and survival was not found, 
irrespective of pretreatment with lactulose. Haemodialysis procedures did not 
increase the risk of endotoxaemia even when dialysates were contaminated with 
endotoxins. 
In chapters V and VI we studied the effect of haemodialysis, 
cross-dialysis and haemofiltration (intermittent and continuous) on survival 
and the neurological state of pigs with ischaemic hepatic necrosis. In 
addition we determined the removal and clearance capacities of several liver 
support systems for putative toxins. Large-pore haernodialysis, cross-dialysis 
and haemofiltration (interoittent or continuous) prolong survival slightly, 
and reduce the rate of deterioration of the EEG. Pronounced improvement of 
the neurological state was not found. Although haemofiltration should remove 
middle molecules more efficiently, this procedure was not superior to 
conventional large-pore haemodialysis as far as survival, neurological 
improvement and removal of small molecular substances were concerned. During 
the dialysis procedures the plasma levels of small molecular toxins, such as 
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ammonia, glutamine, tyrosine and methionine, decreased but normalisation of 
blood levels could not be achieved. In advanced hepatic coma ammonia and 
glutamine increased in spite of efficient removal. 
In chapter VII the data acquired in our studies are discussed in relation 
to the prospectives of artificial liver support. It is concluded that only 
high-flmv systemic portal cross-circulation (400 ml/min) for 16 hours a day 
is sufficient to correct the internal milieu. All other systems are 
inadequate because of their failure to remove 'all' toxins efficiently. Since 
cross-circulation is considered unethical in man, another procedure must with 
an efficacy comparable to that of systemic portal cross-circulation be found. 
Partial auxiliary transplantation of a liver (ATPL) yields a toxin removal 
that is at least similar to that of systemic portal cross-circulation. The 
preliminary results of ATPL in pigs with ischaernic hepatic necrosis are 
encouraging. Efforts should be made to introduce this procedure into clinical 
practice. 
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SAMENVATTING EN CONCLUSIES. 
Vijf jaren onderzoek naar de ontwikkeling van methoden voor de behandeling 
van acute leverinsufficii2.ntie, hebben geresulteerd in de hiernavolgende 
conclusies. 
Een belangrijk doel van het onderzoek beschreven in dit proefschrift was 
bet ont,..rikkelen van een dierrnodel, dat kan worden vergeleken met het humane 
acute leverinsufficientie syndroom, en het ontwikkelen van een betrouwbare en 
obj ectieve 
onderdelen 
methode voor het meten van hepatische encephalopathie. Beide 
de evaluatie van therapeutische zijn noodzakelijk voor 
toepassingen bij acute leverinsufficii2.ntie. 
In hoofdstuk 2 wordt het diermodel van varkens met acute 
leverinsufficiiintie beschreven. Acute leverinsufficientie wordt veroorzaakt 
door tijdelijke ischaemie van de lever. Ischaemie van de lever gedurende 4 
uur werd door 4 van de 8 dieren verdragen, terwijl ischaemie gedurende 6 uren 
binnen 50 uur tot de dood leidde bij 6 van de 7 dieren. Ernstige 
encephalopathie (graad 3 a 4 ), ontwikkelde zich binnen 30 uur in alle dieren 
met 6 uur ischaemie van de lever. De leverbeschadiging in dit model heeft 
theoretisch de mogelijkheid van reversibiliteit: 1. vanwege het hers tel van 
de leverdoorstroming na de ischaemische periode; 2. daar de hoeveelheid 
necrose van de lever na 6 uur ischaemie niet meer dan 75% bedraagt, blijft 
meer dan 25% van de levercellen over voor regeneratie. Met dit diermodel is 
voldaan aan de volgende criteria: 
Reproduceerbaarheid, potentiele reversibiliteit en dood door 
leverinsufficientie met daarbij een voldoende lang tij dsinterval om een 
lever ondersteunende behandeling te kunnen starten. Abnormale aminozuur 
spectra, zoals uitvoerig bij een acute leverinsufficientie beschreven, kon 
ook in dit model worden aangetoond. De metingen van de neutrale aminozuren 
werden niet uitgedrukt als concentraties, maar als plasmaratio 1 s (verhouding 
tussen elk afzonderlijk neutraal aminozuur en de sam van alle neutrale 
aminozuren), omdat de individuele aminozuurratio het beste de influx van 
neutrale aminozuren naar de hersenen weergeeft. De ratio van tyrosine nam 
sterk toe na inductie van levernecrose en bleek te correleren met de mate van 
levercelnecrose. Oak de ratio van phenylalanine en methionine nam toe, doch 
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een correlatie met uitgebreidheid van levernecrose kon niet worden gevonden. 
De ratio's van tyrosine en phenylalanine normaliseerden zich 30 uur na 
inductie van de levernecrose bij dieren die overleefden. De tryptofaan ratio 
veranderde niet in varkens, in tegenstelling tot gegevens over mensen en 
ratten. Aannemende dat verstoringen in bet transport van aminozuren via de 
bloed-bersen barriere bet beste worden weergegeven door de plasmaratio's van 
de neutrale aminozuren, lijken de ratio's van tyrosine en phenylalanine bet 
meest afwijkend te zijn bij hepatische encephalopathie in varkens. Het plasma 
arginine verdwijnt nagenoeg volledig na inductie van levernecrose; na 24 uur 
stijgt de plasma arginine concentratie bij dieren die overleven. 
In boofdstuk 3 worden methoden beschreven voor bet objectief meten van 
hepatische encephalopathie. Het zgn. 'powerspectrum' een door een computer 
verrichte transformatie van bet EEG - werd geevalueerd, daar conventionele 
beoordeling van het BEG subjectief is en klinisch-neurologisch onderzoek bij 
varkens niet betrouwbaar is. Het EEG kan op deze wijze worden vertaald in de 
gemiddelde frequentie en de 'powerspectra' (de sam van golfamplitudes als 
functie van iedere frequentie) van verschillende frequentiebanden. De 
gemiddelde frequentie en de relatieve 'power' van de deltafrequentieband 
waren gevoelige parameters voor bepatische encephalopathie tot graad 3. 
'Visuele evoked potentials' en 'brainstem auditory evoked potentials 1 war en 
sensitieve nocb specifieke indicatoren om encephalopatbie te rneten. 
In hoofdstuk 4 wordt de incidentie van endotoxinaemie en de invloed 
hiervan op de overleving bepaald bij varkens met permanente iscbaernie van de 
lever. Voor de dood nam de incidentie van endotoxinaemie aanzienlijk toe: 
endotoxinaernie kon worden voorkornen door toediening per os van 
rnagnesiumsulfaat en lactulose. Significante relaties tussen bet optreden van 
endotoxinaemie en de overleving werden niet gevonden, onafbankelijk van 
behandeling met lactulose. Haemodialyse procedures vergrootten bet risico 
voor endotoxinaemie niet, zelfs niet wanneer bet badwater gecontamineerd was 
met endotoxines. 
In de hoofdstukken 5 en 6 wordt bet effect van baemodialyse, kruisdialyse 
en haemofiltratie op de overleving en neurologische status van varkens met 
iscbaemische levernecrose bestudeerd. Tevens werden de verwijderings-en 
klaringscapaciteit voor verscbillende toxinen door de verscbillende dialyse 
122 
systemen berekend. Haemodialyse met een grote-gatenmembraan, kruisdialyse en 
haemofiltratie verlengden de overleving enigszins en lieten minder snel 
verslechtering zien van het EEG. Duidelijke neurologische verbetering werd 
niet gevonden. Haemofiltratie bleek niet superieur aan haemodialyse met een 
grote-gatenmembraan, ondanks het feit dat haemofiltratie efficie.nter 
middelgrote moleculen verwijderde. Plasmaconcentraties van kleine moleculaire 
toxinen zoals ammoniak, glutamine, tyrosine en methionine daalden tijdens de 
dialyse procedures, doch normale plasmaspiegels van de toxinen konden niet 
worden bereikt. Bij vergevorderde hepatische encephalopathie namen de 
plasmaconcentraties van ammoniak en glutamine zelfs toe, ondanks efficiente 
klaring. 
In hoofdstuk 7 worden de gegevens, verkregen uit vorige onderzoekingen 
besproken. Daarbij wordt uitgebreid ingegaan op de vooruitzichten van een 
zgn. kunstlever bij acute leverinsufficientie. De uiteindelijke conclusie is 
dat alle huidige systemen een onvoldoende capaciteit hebben om welke toxinen 
dan ook effectief te kunnen verwijderen. Alleen systemische-portale 
kruiscirculatie met een hoge bloedflow kan het gestoord 'milieu interne' 
volledig normaliseren, mits deze procedure 16 uur per dag aangewend wordt. 
Door fatale complicaties bij donoren van kruiscirculatie kan deze procedure 
bij mensen niet gebruikt worden, zodat een andere procedure met dezelfde 
capaciteit als kruiscirculatie moet worden gevonden. Parti€le auxiliaire 
transplantatie van de lever kan in theoretisch opzicht efficienter en 
effectiever dan kruiscirculatie de detoxificatie functie van de lever 
overnemen. De voorlopige resultaten van partiele auxiliaire transplantaties 
van de lever bij varkens met acute leverinsufficientie lijken bemoedigend. 
Aanbevolen wordt deze procedure toepasbaar te maken voor patienten met acute 
leverinsufficientie. 
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VERANTWOORDING 
Dit proefscbrift werd bewerkt op verschillende experimentele chirurgiscbe 
laboratoria. Het slagen van de experimenten was afhankelijk van de enorme 
inzet van velen. Het werken op dergelijke laboratoria was voor mij als 
internist een bijzondere 
boeiend en veelzijdig; 
ervaring. 
selectie 
De 
der 
coOrdinatie was voor 
dieren, buisvesting 
mij leerzaam, 
der dieren, 
prae-operatieve voorbereiding, operatieve procedures, post-operatieve zorg, 
uitdenken en uitvoeren van dialysetechnieken, verricbten van metingen en 
bloedbepalingen, obducties, bistologische bewerkingen en rubriceren van data 
konden alleen verwezenlijkt worden door medewerking van velen. De hemodialyse 
experimenten werden uitgevoerd in bet experimenteel chirurgiscb laboratorium 
van bet Academisch Ziekenbuis Leiden. Dank aan alle medewerkers van het 
laboratorium onder leiding van Drs.H. Stol, tevens aan Hans Terpstra, Jaap 
Lens en }linus de Jonge voor hun voortreffelijke operatieve assistentie. 
Patricia Batavier, I eke Schicht en alle co-assistenten worden bedankt voor 
hun hulp t.a.v. de dialyse experimenten. De ontwikkeling van een 
representatief diermodel voor acute leverinsufficientie en bet uitvoeren van 
bemoperfusie en kruiscirculatie experimenten werden gerealiseerd in bet 
experimenteel chirurgisch laboratorium van de Erasmus Universiteit onder 
leiding van Prof.Westbroek en Rob ten Berge. 
De inzet van Cas, Roy, Enno, Rob, Erik, Pim, Wiebeke en Jannie maakte het 
uitvoeren van vele experimenten mogelijk. 
Bijzondere dank ben ik verschuldigd aan Kees Reuvers, die, ondanks zijn 
kliniscbe werkzaamheden, wekelijks tijd vrij kon maken voor de chirurgische 
ingrepen. 
Ook de hulp van Onno Terpstra en Ton Fick was onontbeerlijk. 
Grote bewondering heb ik voor bet uithoudingsvermogen van Jan Boot, Wim v.d. 
Berg en alle anderen van bet laboratorium Interne II, die gedurende 5 jaar 
met grate nauwkeurigheid de bepaling van toxinen hebben verricht en daarnaast 
hebben meegedacht in de opzet van de experimenten. 
Dank aan Ton Boks die vaak met grate technische vindingrijkheid de 
haemoperfusie experimenten kon laten slagen. 
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De hulp van de afdelingen Pharmacologie (Prof.Bruinsveld), Electrofysiologie 
(Prof. de Vlieger en mede"-'erkers), Pathologie (Dr. F. W .J. ten Kate, 
Dhr. Vroonhoven, Hej. Kiers) , Bacteriologie (Prof. Hichel, Hw. Haas), Centrale 
Research Werkplaats en Bureau Medische Technicologie van de T. H. Eindhoven 
(Ad van Berlo) en Diacare Nederland (Jan Smetsers) is zeer gewaardeerd. De 
apothekers van bet Academisch Ziekenhuis Dijzigt, Academisch Ziekenhuis 
Leiden en Holy Ziekenhuis worden bedankt voor hun hulp bij de hemofiltratie 
experimenten. 
Dank aan Ivonne Pijpers, die nauwgezet alle tikwerk voor dit proefschrift 
heeft verricht. 
Prof.Frenkel, van wie ik mijn internistische opleiding mocht genieten, heeft 
mij altijd gestimuleerd en de gelegenheid gegeven om dit wetenschappelijk 
werk te voltooien. Ret is voor mij een grate eer hem als promotor te mogen 
voordragen. 
Last, but not least, wilde ik Solko Schalm bedanken voor zijn enorme inzet om 
dit werk te kunnen voltooien. Solko, meer dan wie ook weten wij wat bet is om 
dergelijke experimenten, waarbij zo veel mensen betrokken waren, tot ieders 
tevredenheid af te ronden. Mede door jouw optimisme, doorzettingsvermogen, 
medewerkzaamheid en enthousiasme is dit gelukt. 
Tenslotte dank aan allen, die direct of indirect door middel van vriendschap 
en steun mij in de gelegenheid gesteld hebben om dit werk te kunnen afronden. 
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CURRICULUl"l VITAE 
De schrijver van dit proefschrift werd geboren op 21 maart 1951 te Vroomsboop. 
In 1970 werd bet eindexamen H.B.S.-B aan bet Cbristelijk Lyceum te Almelo 
behaald. 
Aansluitend werd de medicijnen-studie aangevangen aan de Erasmus Universiteit 
te Rotterdam, alwaar in 1975 het Doctoraal-examen en in 1977 het Artsexamen 
werd afgelegd. 
Op 21 Februari 1977 werd de opleiding tot internist aangevangen in bet 
Academiscb Ziekenhuis Rotterdam, Dijkzigt, onder leiding van Prof.Dr.M. 
Frenkel. 
In Februari 1982 werd de schrijver in het Specialisten Register ingeschreven. 
Vanaf October 1981 tot en met Februari 1983 bekwaamde hij zich op de afdeling 
Interne Geneeskunde II van het Academisch Ziekenhuis Rotterdam in de 
hepatologie en de gastro-enterologie onder leiding van Dr.S.W. Schalm. 
Hij is thans werkzaam als internist in bet Sint Jozef Ziekenhuis te Heemskerk. 
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